Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020717	p-zn	umol/l (umol/l)	1737	2757	0.07%
3020717	b-zn	umol/l (umol/l)	346	420	0.00%	Distribution not available
3020717	p-zn	— (—)	161	198	100.00%	Distribution not available
3020717	b-zn	— (—)	6	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis

455

1106

4.14

165.66

1.4

1.5

19.95

26.86

umol/l

5.24

438

1041

Dermatitis and eczema

707

1391

3.17

151.08

1.4

1.6

21.46

26.29

umol/l

3.67

683

1315

Other and unspecified dermatitis

391

915

4.32

150.72

1.4

1.6

19.03

27.34

umol/l

6.62

378

858

ILD medications: immunosuppressive drugs

420

1184

3.32

109.05

1.6

1.5

17.34

26.59

umol/l

10.16

403

1131

Diseases of the skin and subcutaneous tissue

518

844

3.09

99.19

1.6

20.56

29.41

umol/l

7.18

497

797

Autoimmune diseases excluding thyroid diseases, strict definition

557

1080

2.84

95.45

1.7

1.5

19.28

26.78

umol/l

6.80

522

1037

ILD medications

636

1311

2.64

95.41

1.6

1.5

22.16

25.98

umol/l

2.20

609

1246

Autoimmune diseases excluding thyroid diseases

571

1123

2.79

94.71

1.7

1.5

19.46

27.00

umol/l

6.92

536

1075

GASTRO-related operations

446

696

3.23

91.34

1.8

1.2

20.32

28.90

umol/l

6.16

432

658

Any gastric operation

446

696

3.23

91.34

1.8

1.3

20.32

28.90

umol/l

6.16

432

658

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

559

1457

2.66

91.25

1.8

1.4

20.36

26.50

umol/l

5.04

536

1383

Dental caries

188

352

5.19

89.66

1.8

1.6

16.47

29.32

umol/l

7.43

183

343

Other disorders of skin and subcutaneous tissue

397

1168

3.04

88.26

1.5

1.4

20.41

26.56

umol/l

3.74

375

1106

Disorders of skin appendages

335

1032

3.27

86.55

1.3

1.6

20.58

26.63

umol/l

3.50

319

988

ILD medications: prednisolone, methylprednisolone, prednisone

588

1276

2.59

85.78

1.7

1.5

22.76

26.31

umol/l

1.80

561

1213

First line medication for Crohn's disease

605

1289

2.55

84.62

1.6

1.5

23.72

24.33

umol/l

0.17

583

1226

Autoimmune diseases

580

1130

2.62

84.07

1.7

1.5

20.55

26.96

umol/l

5.10

552

1082

Autoimmune diseases related-to ILD

480

1547

2.67

83.35

1.6

1.5

20.81

26.14

umol/l

3.68

458

1470

Caries of dentine

165

300

5.41

82.77

1.8

1.6

14.85

30.43

umol/l

9.75

160

293

Persons encountering health services for specific procedures and health care

601

1468

2.47

81.21

1.8

1.4

24.39

24.36

umol/l

0.01

583

1387

Used for control exclusion in common control thyroid runs

542

1038

2.65

79.99

1.6

1.5

21.08

26.55

umol/l

3.54

513

997

General symptoms and signs

562

1088

2.60

79.77

1.6

1.5

23.51

25.24

umol/l

0.58

535

1034

Examination and observation for other reasons

313

504

3.61

79.65

1.7

1.3

20.57

29.68

umol/l

4.77

299

475

Intestinal stricture

202

488

4.18

74.99

2.9

1.3

17.33

24.52

umol/l

3.22

194

464

Anxiety disorders, excluding more controls

462

1132

2.67

74.83

1.7

1.4

21.83

28.55

umol/l

4.65

437

1079

Other nutritional deficiencies

397

1385

2.72

72.97

1.8

1.4

16.72

27.14

umol/l

13.46

379

1319

Fever of other and unknown origin

300

842

3.19

72.59

1.9

1.4

23.33

25.71

umol/l

0.64

293

802

Endocrine, nutritional and metabolic diseases

450

828

2.77

71.92

1.8

1.3

21.82

28.27

umol/l

3.82

429

791

Nutritional anaemias

282

847

3.23

71.07

1.9

1.5

16.04

25.51

umol/l

8.63

267

801

Noninfective enteritis and colitis

301

982

3.09

70.71

2.1

1.5

22.17

24.91

umol/l

0.85

284

940

Obesity, other/unspecified

248

721

3.47

70.59

1.9

1.4

15.52

28.52

umol/l

13.40

241

690

Diseases of the digestive system

265

804

3.30

69.78

2.7

1.4

15.86

25.16

umol/l

8.31

254

767

Neurotic, stress-related and somatoform disorders

500

1436

2.45

69.49

1.7

1.5

21.07

26.31

umol/l

3.65

475

1366

Anxiety disorders

501

1441

2.43

68.76

1.7

1.5

21.20

26.31

umol/l

3.49

476

1371

Oedema, not elsewhere classified

188

452

4.14

68.71

1.6

1.4

16.88

26.56

umol/l

4.89

180

427

General examination and investigation of persons without complaint and reported diagnosis

317

507

3.28

67.63

1.7

1.3

23.84

29.60

umol/l

1.96

296

477

Inflammatory bowel disease treatment related agents

587

1429

2.31

67.54

1.6

1.5

22.60

25.59

umol/l

1.44

558

1359

Complications of medical and surgical care

395

1407

2.60

66.12

1.9

1.4

19.00

26.69

umol/l

6.39

374

1338

Medical observation and evaluation for suspected diseases and conditions

317

507

3.21

65.12

1.8

1.3

23.39

29.60

umol/l

2.27

297

477

Other special examinations and investigations of persons without complaint or reported diagnosis

318

507

3.19

64.40

1.7

1.3

22.14

29.60

umol/l

3.17

303

477

Oral corticosteroids

533

1359

2.34

64.19

1.6

1.5

23.26

25.96

umol/l

1.11

506

1290

Paralytic ileus and intestinal obstruction

156

352

4.47

63.29

3.0

1.3

18.26

26.10

umol/l

2.69

150

333

Other diseases of intestines

550

1378

2.28

61.94

1.8

1.5

22.82

25.08

umol/l

0.93

531

1313

Other septicaemia

210

570

3.57

61.90

2.2

1.4

15.11

26.49

umol/l

8.35

200

536

Tramadol

390

913

2.64

60.87

1.8

1.3

18.29

28.71

umol/l

9.98

374

866

Septicaemia

224

626

3.37

60.04

2.3

1.5

15.41

26.41

umol/l

8.38

214

591

Other bacterial diseases

466

1329

2.37

59.78

1.9

1.4

19.04

26.80

umol/l

7.04

448

1258

Oxycodone

193

471

3.73

59.76

1.8

1.3

27.83

28.34

umol/l

0.06

181

445

Chronic pancreatitis

101

170

6.04

57.37

2.1

1.3

22.05

25.20

umol/l

0.40

163

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

314

1162

2.68

57.13

2.0

1.4

17.07

27.32

umol/l

10.32

297

1106

Care involving use of rehabilitation procedures

335

1184

2.62

57.11

1.9

1.4

21.17

24.68

umol/l

1.44

329

1113

Gastrointestinal diseases

311

525

2.98

56.48

1.8

1.4

22.34

27.65

umol/l

1.98

299

497

Explicit Sepsis

238

718

3.12

56.15

2.3

1.5

16.00

26.06

umol/l

7.63

227

683

Second line medication for Crohn's disease

327

1267

2.60

55.85

1.5

17.77

26.63

umol/l

8.09

314

1207

Other bacterial diseases

501

1429

2.23

55.54

1.9

1.4

19.59

26.85

umol/l

6.54

481

1356

Other disorders of skin and subcutaneous tissue, not elsewhere classified

118

238

5.03

55.06

1.7

1.4

14.80

25.75

umol/l

4.62

113

225

L04AX Other immunosuppressants

316

1221

2.60

54.30

1.5

17.54

26.55

umol/l

8.18

304

1162

Persons encountering health services for other counselling and medical advice, not elsewhere classified

530

1319

2.19

53.92

1.8

1.4

24.07

25.32

umol/l

0.39

508

1251

Obesity

350

1372

2.48

53.76

1.7

1.4

16.33

27.38

umol/l

14.32

338

1301

Obesity and other hyperalimentation

351

1376

2.47

53.72

1.7

1.4

16.32

27.40

umol/l

14.44

339

1304

Complications of surgical and medical care, not elsewhere classified

480

1485

2.22

53.63

1.9

1.4

19.68

26.64

umol/l

5.88

453

1411

Complications of procedures, not elsewhere classified

403

1428

2.35

53.32

1.9

1.4

19.90

26.83

umol/l

5.17

382

1358

Recurrent or chronic depression

234

519

3.19

53.13

1.6

1.4

22.27

29.15

umol/l

2.48

221

493

Opioids

469

1069

2.29

52.01

1.7

1.4

22.74

27.90

umol/l

2.73

452

1011

Malaise and fatigue

242

659

2.97

50.80

1.8

1.5

23.63

25.98

umol/l

0.52

234

626

Obesity due to excess calories

274

1021

2.70

50.74

1.7

1.5

14.86

27.72

umol/l

17.37

265

976

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

291

1116

2.62

50.69

1.9

1.4

16.92

26.74

umol/l

9.17

275

1063

Other or unspecified ileus, impaction or obstruction

113

236

4.83

50.53

3.4

1.3

18.24

25.45

umol/l

1.80

108

223

Headache

324

1029

2.53

49.96

1.6

1.5

24.54

25.26

umol/l

0.15

307

977

Other reaction to severe stress, and adjustment disorders

231

795

2.93

49.72

1.9

1.5

18.30

26.99

umol/l

5.52

219

765

Iron deficiency anaemia

227

764

2.95

49.32

1.7

1.5

17.38

25.40

umol/l

5.00

214

726

Persons encountering health services in other circumstances, wide

536

1320

2.10

48.30

1.7

1.4

23.57

25.31

umol/l

0.61

512

1252

Any reimbursement code in KELA

312

584

2.69

47.54

1.8

1.3

23.52

26.30

umol/l

0.75

296

553

Nausea and vomiting

164

468

3.46

46.47

2.1

1.6

21.37

26.35

umol/l

1.29

156

449

Disorders of gallbladder, biliary tract and pancreas

455

1342

2.15

45.86

1.9

1.4

20.82

26.56

umol/l

3.83

433

1275

Implicit bacterial Sepsis

186

517

3.21

45.61

1.8

1.4

15.35

26.73

umol/l

7.58

181

490

Bacterial Sepsis

213

618

2.96

45.23

1.9

1.4

16.18

27.03

umol/l

7.44

208

589

Mood disorders, excluding more controls

424

1168

2.17

43.61

1.6

1.4

19.58

28.42

umol/l

7.93

398

1113

Benzodiazepine use

467

1564

2.06

43.50

1.6

1.5

22.03

25.88

umol/l

1.97

441

1489

Other and unspecified iron deficiency

186

617

3.03

42.77

1.7

1.5

18.80

25.53

umol/l

2.85

177

587

Other noninfective gastroenteritis and colitis

166

516

3.24

42.65

2.2

1.6

21.58

23.82

umol/l

0.43

155

494

Diseases of oesophagus, stomach and duodenum

488

1436

2.04

42.64

1.6

1.5

22.15

25.94

umol/l

1.93

459

1371

Hypothyroidism, strict autoimmune

316

862

2.42

42.56

1.5

1.4

23.22

28.02

umol/l

1.87

303

829

Codeine

418

1043

2.18

42.41

1.5

1.3

21.12

28.08

umol/l

4.59

405

987

Depression

457

1507

2.06

42.41

1.7

1.5

19.37

26.62

umol/l

6.68

429

1438

Implicit bacterial Sepsis

197

576

2.97

42.19

1.9

1.4

15.68

27.11

umol/l

7.90

191

547

Atopic dermatitis, strict definition with reimbursement

202

681

2.89

42.12

1.7

21.47

24.98

umol/l

1.01

197

651

Certain infectious and parasitic diseases

451

1063

2.13

42.10

1.6

1.4

22.69

26.40

umol/l

1.61

433

1009

Bacterial infection, other or unspecified

234

758

2.69

41.89

2.2

1.4

19.47

26.98

umol/l

3.58

224

717

Disorders of other endocrine glands

245

939

2.58

41.44

1.8

1.6

19.15

25.14

umol/l

3.05

239

893

Persons encountering health services for examination and investigation

270

507

2.68

41.02

1.7

1.3

22.59

29.60

umol/l

2.65

259

477

All anxiety disorders

328

1136

2.29

40.92

1.6

1.5

20.89

26.56

umol/l

3.17

315

1088

Aplastic and other anaemias

207

691

2.81

40.81

1.8

1.4

17.53

25.10

umol/l

3.89

198

653

Bacterial infection, other or unspecified

251

830

2.57

40.72

2.1

1.4

20.70

27.02

umol/l

2.70

240

782

Atopic dermatitis

308

1084

2.34

40.59

1.6

1.7

21.44

26.25

umol/l

2.27

300

1030

Pain in joint

262

647

2.59

40.31

1.5

22.87

26.75

umol/l

1.16

252

612

Anxiety (asthma-related co-morbidities)

324

1100

2.29

40.11

1.6

1.5

21.01

27.55

umol/l

3.92

311

1058

Other anaemias

194

646

2.87

40.04

1.8

1.4

17.90

24.68

umol/l

2.99

186

611

Symptoms and signs involving the digestive system and abdomen

431

1019

2.13

40.02

1.6

1.5

22.16

25.54

umol/l

1.39

409

977

Other antidepressants

448

1104

2.09

39.89

1.6

1.5

23.05

26.61

umol/l

1.48

426

1054

Other and unspecified anaemias

192

639

2.88

39.88

1.8

1.4

17.99

24.82

umol/l

2.97

184

604

Implicit Sepsis

326

1086

2.27

39.52

1.8

1.4

17.14

26.81

umol/l

9.36

313

1027

Implicit Sepsis

361

1215

2.18

39.31

1.7

1.4

17.83

27.04

umol/l

8.92

344

1153

Mood [affective] disorders

470

1535

1.99

39.30

1.6

1.5

19.61

26.76

umol/l

6.53

442

1464

Mood disorders

470

1537

1.98

38.97

1.6

1.5

19.61

26.79

umol/l

6.57

442

1466

Abdominal and pelvic pain

426

1017

2.11

38.90

1.6

1.5

22.01

25.56

umol/l

1.51

404

975

Inflammatory bowel disease

188

664

2.85

38.74

1.9

1.5

21.22

25.71

umol/l

1.30

179

634

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

458

1506

1.99

38.14

1.9

1.5

21.97

25.26

umol/l

1.53

436

1437

Diarrhoea and gastroenteritis of presumed infectious origin

462

1546

1.98

38.02

1.7

1.5

23.71

24.85

umol/l

0.33

436

1473

Any mental disorder

475

1194

2.00

37.59

1.7

1.4

20.23

28.07

umol/l

6.80

450

1137

Crohn disease

104

258

4.08

37.58

2.3

1.5

16.31

24.13

umol/l

2.44

245

Intestinal infectious diseases

438

1681

1.98

37.56

1.9

1.5

22.04

24.82

umol/l

1.17

414

1601

Diarrhoea and gastroenteritis of presumed infectious origin

338

1418

2.16

37.41

2.0

1.5

21.29

24.87

umol/l

1.48

319

1356

Low back pain

344

1143

2.17

36.90

1.7

1.5

21.85

26.35

umol/l

1.99

325

1090

Condition for Implicit Sepsis (Organ dysfunction codes)

372

1255

2.10

36.62

1.7

1.4

17.88

26.94

umol/l

8.90

355

1192

Mycoses

156

516

3.05

36.22

2.2

1.5

18.59

24.06

umol/l

1.81

148

494

Other anxiety disorders

251

903

2.42

36.21

1.6

1.5

21.13

26.67

umol/l

2.37

242

870

Other functional intestinal disorders

217

790

2.56

35.81

1.9

1.5

24.49

25.24

umol/l

0.13

207

751

Mycoses

389

1697

2.00

35.13

1.7

1.5

22.34

25.20

umol/l

1.14

364

1621

Other disorders of fluid, electrolyte and acid-base balance

149

463

3.08

34.98

2.4

1.4

16.00

26.73

umol/l

5.52

141

438

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

401

1200

2.03

34.87

1.9

1.4

19.82

26.87

umol/l

5.12

383

1139

401

1200

2.03

34.87

1.9

1.4

19.82

26.87

umol/l

5.12

383

1139

Dorsalgia

441

1197

1.98

34.72

1.5

22.27

26.05

umol/l

1.76

419

1141

Implicit viral Sepsis

145

471

3.10

34.71

1.9

1.4

14.61

26.07

umol/l

8.52

140

448

Intestinal infectious diseases

501

1527

1.88

34.53

1.6

1.5

24.03

24.96

umol/l

0.26

472

1455

Condition for Implicit Sepsis (Organ dysfunction codes)

392

1345

2.02

34.51

1.7

1.4

18.74

26.62

umol/l

6.96

374

1280

Renal failure

185

603

2.73

34.20

2.0

1.5

13.82

24.86

umol/l

9.94

177

573

Depression or dysthymia

280

659

2.35

33.96

1.6

1.4

18.43

28.53

umol/l

6.96

263

626

Other soft tissue disorders, not elsewhere classified

424

1264

1.97

33.84

1.6

22.21

25.13

umol/l

1.18

408

1207

Erysipelas

221

792

2.48

33.78

1.6

1.4

17.40

27.32

umol/l

6.21

214

743

Other diseases of lip and oral mucosa

204

809

2.54

33.53

1.3

1.5

23.01

26.52

umol/l

0.92

195

768

Codeine or tramadol medication

483

1407

1.88

33.18

1.5

20.86

26.85

umol/l

4.27

466

1327

Infections of the skin and subcutaneous tissue

280

1268

2.20

33.15

1.9

1.5

15.41

25.54

umol/l

12.32

273

1211

Certain infectious and parasitic diseases

312

700

2.24

32.94

1.6

1.4

22.43

26.56

umol/l

1.41

294

671

Gastro-oesophageal reflux disease

295

1180

2.16

32.86

1.5

23.22

26.02

umol/l

0.84

273

1122

IBD patients in KELA-register

140

464

3.04

32.46

1.8

1.5

22.93

25.48

umol/l

0.44

133

443

Erysipelas

281

973

2.21

32.19

1.5

1.4

18.69

27.38

umol/l

5.56

272

914

Psychiatric diseases

417

1061

1.97

32.05

1.6

1.5

20.52

28.03

umol/l

5.55

397

1012

Metabolic disorders

412

1298

1.94

31.86

2.2

1.4

18.98

27.36

umol/l

7.89

399

1233

Lower back pain or/and sciatica

449

1574

1.87

31.41

1.6

1.4

21.47

25.87

umol/l

2.51

424

1497

Asthma, excluding more controls

316

768

2.15

30.79

1.7

1.5

22.76

27.50

umol/l

1.81

303

728

Depression medications

154

248

3.14

30.67

1.6

1.5

22.15

25.08

umol/l

0.51

145

243

Irritable bowel syndrome

150

535

2.82

30.48

1.5

1.4

27.89

27.12

umol/l

0.10

141

504

Crohn's disease of large intestine

5.78

30.42

2.2

1.5

14.10

24.90

umol/l

2.53

Influenza and pneumonia

468

1641

1.82

29.93

1.9

1.4

19.61

26.00

umol/l

5.33

446

1563

Abnormalities of breathing

398

1204

1.93

29.72

1.5

1.6

24.61

23.81

umol/l

0.19

374

1158

Neurological diseases

386

986

1.97

29.70

1.7

1.5

21.48

26.52

umol/l

2.54

369

947

Constipation

379

1363

1.93

29.67

1.5

22.45

25.65

umol/l

1.26

356

1306

Other pulmonary diagnosis

337

817

2.07

29.56

1.6

1.5

23.15

26.93

umol/l

1.30

323

772

Pain (limb, back, neck, head abdominally)

297

685

2.18

29.48

1.5

1.6

22.98

26.05

umol/l

0.87

285

649

Candidiasis

163

618

2.66

29.47

2.0

1.5

18.96

25.26

umol/l

2.49

152

588

Asthma

323

812

2.09

29.39

1.7

1.5

22.59

27.00

umol/l

1.67

308

768

Cardiovascular diseases (excluding rheumatic etc)

339

962

2.03

29.38

1.7

1.6

22.64

27.09

umol/l

1.85

326

918

Excluding asthma or asthma-COPD overlap

336

817

2.07

29.25

1.6

1.5

23.90

26.93

umol/l

0.91

322

772

Inflammatory bowel disease, strict (require KELA)

140

496

2.84

28.86

1.8

1.5

22.93

25.32

umol/l

0.41

133

473

Asthma (only as main-diagnosis), excluding more controls

288

768

2.15

28.79

1.6

1.5

22.45

27.50

umol/l

1.93

275

728

Asthma (mode)

319

825

2.08

28.68

1.6

1.5

22.95

26.72

umol/l

1.30

304

781

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

163

283

2.90

28.65

1.6

1.7

24.00

27.53

umol/l

0.62

156

273

Episodal and paroxysmal disorders

475

1338

1.81

28.50

1.7

1.5

23.07

25.37

umol/l

0.86

455

1278

Pneumonia, organism unspecified

396

1485

1.87

28.50

2.0

1.4

19.12

26.28

umol/l

5.74

379

1416

Pneumonias (Asthma/COPD co-morbidities)

442

1639

1.82

28.49

2.0

1.5

19.30

26.05

umol/l

5.77

424

1560

All kidney diseases

432

1623

1.82

28.39

1.8

1.4

18.40

26.25

umol/l

8.00

412

1545

Ulcerative colitis

134

469

2.88

28.25

1.8

1.5

23.62

24.91

umol/l

0.19

128

449

Other dorsopathies, not elsewhere classified

427

1202

1.86

28.23

1.5

22.69

25.99

umol/l

1.38

409

1146

5-aminosalicylic acid

121

403

3.02

27.88

1.9

1.5

22.87

24.79

umol/l

0.29

114

388

All pneumoniae

443

1648

1.80

27.83

1.9

1.5

19.27

25.97

umol/l

5.72

425

1569

Cystic fibrosis with pulmonary manifestations

+∞

27.74

3.5

0.0

13.14

—

umol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

432

1632

1.81

27.70

1.9

1.5

19.42

26.00

umol/l

5.37

414

1557

L04AA Selective immunosuppressants

137

492

2.81

27.57

2.0

1.5

16.25

25.07

umol/l

3.99

129

470

Somatoform disorder

105

324

3.27

27.55

1.6

1.4

24.01

25.45

umol/l

0.17

311

COPD differential diagnosis

332

825

2.02

27.35

1.6

1.5

24.10

26.72

umol/l

0.73

317

781

ILD differential diagnosis

332

825

2.02

27.35

1.6

1.5

24.10

26.72

umol/l

0.73

317

781

Other and unspecified polyneuropathies, also in other diseases

273

3.47

27.14

1.8

1.4

17.89

24.52

umol/l

1.46

262

Pain in limb

349

1219

1.92

26.81

1.6

19.94

25.26

umol/l

3.03

340

1164

Viral infections characterized by skin and mucous membrane lesions

376

1748

1.84

26.75

1.5

1.6

21.96

25.15

umol/l

1.37

356

1667

Asthma (only as main-diagnosis)

290

812

2.07

26.57

1.6

1.5

22.64

27.00

umol/l

1.54

277

768

Visual disturbances and blindness

230

1077

2.14

25.83

1.6

1.5

24.20

24.74

umol/l

0.09

216

1026

Hypertensive diseases (excluding secondary)

252

679

2.16

25.74

1.6

1.5

19.67

28.98

umol/l

5.33

246

647

Hypothyroidism, other/unspecified

379

1354

1.85

25.74

1.5

24.65

24.57

umol/l

0.02

362

1294

Hypothyreosis and Thyroxine purchase for inclusion criteria

390

1408

1.82

25.40

1.5

24.61

24.95

umol/l

0.07

373

1343

Neurological diseases, wide definition

159

294

2.73

25.19

1.8

1.5

21.63

28.25

umol/l

1.71

151

285

Visual disturbances

217

1007

2.16

25.00

1.6

1.5

24.53

24.85

umol/l

0.05

203

962

Systemic connective tissue disorders

164

677

2.44

24.90

1.7

1.4

21.37

26.17

umol/l

1.26

156

640

Renal tubulo-interstitial diseases

364

1484

1.83

24.77

1.8

1.4

17.34

26.64

umol/l

10.39

346

1413

Personality disorders, excluding more controls

133

498

2.69

24.71

1.5

20.80

28.68

umol/l

2.43

126

478

Cardiovascular diseases

315

865

1.96

24.51

1.7

23.05

25.85

umol/l

0.88

300

826

Symptoms and signs involving the circulatory and respiratory systems

429

1208

1.78

24.51

1.6

27.01

23.78

umol/l

1.18

408

1162

Polyneuropathies and other disorders of the peripheral nervous system

102

333

3.08

24.40

1.8

1.5

18.14

23.95

umol/l

1.30

318

Parasetamol

309

792

1.98

24.30

1.6

1.4

20.71

29.12

umol/l

5.02

295

761

Sleep apnoea

369

1312

1.83

24.16

1.5

23.35

26.23

umol/l

0.99

348

1248

Persons encountering health services in other circumstances

179

775

2.31

24.09

1.7

1.4

21.80

25.44

umol/l

0.91

166

739

Symptoms and signs involving the skin and subcutaneous tissue

301

1558

1.90

23.99

1.5

23.63

25.15

umol/l

0.38

285

1486

Symptoms and signs involving the nervous and musculoskeletal systems

248

1233

2.02

23.77

1.4

1.5

24.11

24.72

umol/l

0.11

240

1177

Acute upper respiratory infections of multiple and unspecified sites

328

1306

1.87

23.70

1.7

1.5

22.30

24.92

umol/l

0.89

320

1243

Acute renal failure

289

3.20

23.49

2.0

1.4

14.02

24.22

umol/l

4.13

273

Papulosquamous disorders

175

764

2.30

23.44

1.3

1.5

19.34

26.63

umol/l

3.01

168

725

Spondylopathies

292

891

1.96

23.37

1.6

1.4

22.58

27.02

umol/l

1.57

278

845

Follow-up examination after treatment for conditions other than malignant neoplasms

160

427

2.49

23.21

1.5

1.3

21.69

30.58

umol/l

2.91

154

402

KRA_PSY_EATING, excluding more controls

177

3.87

22.97

1.7

1.5

20.24

25.26

umol/l

0.71

172

Covid-19 confirmed case

161

687

2.36

22.74

1.8

1.5

17.67

24.02

umol/l

2.39

146

656

Other symptoms and signs involving the digestive system and abdomen

291

3.15

22.59

1.5

1.4

23.04

27.45

umol/l

0.65

280

Sleep apnoea, including avohilmo

390

1374

1.76

22.56

1.5

24.55

26.07

umol/l

0.41

370

1308

Other specific joint derangements/joint disorders

329

1152

1.85

22.53

1.5

1.6

22.67

26.50

umol/l

1.50

314

1102

Cystic fibrosis

67.86

22.48

3.4

1.0

13.03

28.16

umol/l

—

Other/unspecified dorsalgia

161

685

2.34

22.41

1.6

1.5

23.13

26.46

umol/l

0.69

155

650

Genitourinary diseases

243

581

2.10

22.32

1.8

1.6

20.04

27.07

umol/l

3.11

234

558

Asthma-related infections

253

1269

1.96

22.25

1.8

1.5

20.05

24.49

umol/l

1.88

239

1210

Asthma, hospital admission 2, infections

253

1269

1.96

22.25

1.8

1.5

20.05

24.49

umol/l

1.88

239

1210

Cholelithiasis, broad definition with cholecystitis

335

1238

1.83

22.19

1.8

1.4

20.46

26.94

umol/l

3.85

321

1178

Disorders of lacrimal system

190

876

2.17

22.17

1.7

1.4

21.19

26.60

umol/l

1.82

178

824

Dorsopathies

419

1228

1.74

22.10

1.6

1.5

23.72

25.81

umol/l

0.67

403

1172

Sleep disorders (combined)

444

1372

1.70

21.94

1.5

23.86

25.29

umol/l

0.42

424

1312

Hypokalaemia

184

3.73

21.91

3.3

1.3

17.37

25.38

umol/l

1.57

173

Disorders of the thyroid gland

377

1401

1.76

21.83

1.4

1.5

26.27

24.59

umol/l

0.45

357

1335

Ulcerative colitis, NAS

262

3.23

21.76

1.7

1.5

21.23

25.53

umol/l

0.70

248

COPD/asthma related infections

415

1200

1.74

21.72

1.7

1.4

24.46

26.87

umol/l

0.79

392

1139

COPD/asthma/ILD related infections

415

1200

1.74

21.72

1.7

1.4

24.46

26.87

umol/l

0.79

392

1139

Symptoms and signs involving cognition, perception, emotional state and behaviour

388

1530

1.73

21.65

1.6

1.5

23.50

25.42

umol/l

0.58

365

1460

Obesity related asthma

156

675

2.32

21.39

1.6

1.5

20.21

26.10

umol/l

1.82

146

646

Exposure to unspecified factor

411

1753

1.69

21.23

1.7

1.5

20.63

25.29

umol/l

2.78

392

1668

206

992

2.07

21.15

1.9

1.6

19.55

24.83

umol/l

2.14

194

951

Hypoplasia of dental enamel

7.42

21.06

2.8

2.5

15.16

13.96

umol/l

0.21

Vasomotor and allergic rhinitis

184

842

2.15

20.98

1.5

1.6

24.95

24.11

umol/l

0.14

176

810

Other symptoms and signs involving the nervous and musculoskeletal systems

188

885

2.13

20.97

1.3

1.6

27.07

24.94

umol/l

0.39

183

841

Osteopathies and chondropathies

228

1069

1.99

20.95

1.9

1.5

20.08

25.52

umol/l

2.23

217

1010

Acute upper respiratory infections

411

1495

1.70

20.88

1.5

23.96

25.23

umol/l

0.36

393

1418

Chronic rhinitis, nasopharyngitis and pharyngitis

146

621

2.36

20.83

1.5

30.94

24.97

umol/l

1.23

141

595

444

1370

1.68

20.79

1.6

1.4

23.40

25.75

umol/l

0.85

420

1301

Nonorganic sleeping disorders, excluding more controls

102

365

2.81

20.78

1.5

1.4

24.23

28.20

umol/l

0.62

349

Use of hypnotics and sedatives

417

1416

1.69

20.74

1.7

1.5

22.36

25.70

umol/l

1.42

395

1352

Other diseases of upper respiratory tract

425

1310

1.69

20.67

1.6

24.82

24.21

umol/l

0.14

404

1246

Provisional assignment of new diseases of uncertain etiology

225

1136

1.98

20.66

1.7

1.5

20.83

24.70

umol/l

1.27

207

1087

Codes for special purposes

225

1137

1.98

20.61

1.7

1.5

20.83

24.69

umol/l

1.26

207

1088

Finngen Rheumatological endpoints

401

1337

1.71

20.57

1.5

22.67

26.66

umol/l

1.72

383

1274

Other disorders of lacrimal gland

160

712

2.26

20.56

1.7

1.4

19.63

26.75

umol/l

2.66

149

671

All influenza

118

458

2.59

20.50

2.2

1.5

16.50

25.45

umol/l

3.84

107

437

Osteoporosis

107

368

2.73

20.36

2.4

1.4

17.16

25.72

umol/l

2.71

100

344

Chronic sinusitis

180

845

2.14

20.20

2.1

1.4

23.67

25.52

umol/l

0.36

170

804

Urticaria and erythema

185

879

2.12

20.19

1.8

1.6

19.73

26.26

umol/l

2.81

177

843

Bronchitis

426

1619

1.66

20.08

1.7

1.4

22.15

25.63

umol/l

1.63

409

1535

Other diseases of the digestive system

119

470

2.54

19.95

2.2

1.4

16.75

24.26

umol/l

2.80

113

451

Pain in throat and chest

335

1136

1.78

19.83

1.4

1.6

26.41

24.18

umol/l

0.59

310

1093

Disorders of eyelid, lacrimal system and orbit

335

1459

1.75

19.73

1.5

22.15

25.97

umol/l

1.57

320

1386

Other systemic involvement of connective tissue (FG)

118

462

2.53

19.58

1.6

1.5

22.52

27.98

umol/l

1.11

112

438

Cholelithiasis

316

1225

1.78

19.54

1.7

1.4

20.15

26.88

umol/l

4.00

303

1166

All chronic kidney diseases

203

815

2.04

19.54

1.7

1.5

15.12

25.83

umol/l

9.63

193

776

Migraine

233

976

1.94

19.42

1.6

1.5

23.05

26.08

umol/l

0.84

221

931

Neoplasms

336

1007

1.77

19.23

1.6

26.31

22.69

umol/l

1.21

322

967

Sciatica+with lumbago

199

918

2.00

18.52

1.5

1.4

20.44

26.71

umol/l

2.67

187

871

Abnormalities of heart beat

146

642

2.24

18.39

1.2

1.5

29.35

24.23

umol/l

0.99

133

615

Other heart diseases

213

699

2.00

18.37

1.5

1.6

23.92

27.73

umol/l

0.96

201

668

Other diseases of urinary system

391

1320

1.67

18.36

1.8

1.5

22.03

25.99

umol/l

1.85

374

1257

Myalgia

115

466

2.48

18.33

1.5

21.51

26.50

umol/l

1.08

107

444

Candidiasis

285

2.94

18.32

2.7

1.4

15.30

23.05

umol/l

2.80

271

Other diseases of hard tissues of teeth

212

539

2.04

18.29

1.5

21.44

29.52

umol/l

3.11

198

516

Noninfectious colitis NAS

264

3.02

18.29

2.3

1.5

23.23

23.57

umol/l

0.03

251

Asthma, unspecified (mode), excluding more controls

193

709

2.04

18.28

1.7

1.4

22.31

27.65

umol/l

1.65

183

672

Diseases of the respiratory system

257

677

1.91

18.24

1.6

1.5

23.12

27.15

umol/l

1.20

245

639

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

197

966

1.99

18.18

1.5

23.19

24.90

umol/l

0.34

186

920

Hypertension

325

1050

1.75

18.17

1.5

19.52

27.64

umol/l

5.66

316

999

Diseases of oral cavity, salivary glands and jaws

213

541

2.03

18.13

1.5

21.53

29.48

umol/l

3.01

201

517

Substance abuse, excluding more controls

196

836

2.00

18.10

1.8

1.4

14.04

27.84

umol/l

16.93

189

799

Other headache syndromes

180

882

2.05

18.09

1.6

1.4

22.25

26.52

umol/l

1.20

172

838

Hypertensive diseases

325

1052

1.75

18.07

1.5

19.52

27.60

umol/l

5.62

316

1001

Heart failure, not strict

261

964

1.84

17.99

1.5

15.40

26.92

umol/l

11.60

248

915

Other disorders of urethra and urinary system

282

1139

1.79

17.96

1.8

1.4

21.32

26.09

umol/l

2.02

267

1083

Viral and other specified intestinal infections

145

632

2.22

17.92

2.0

1.6

19.01

23.84

umol/l

1.51

138

605

Irregular menses

242

1027

1.87

17.89

1.6

1.4

22.78

26.52

umol/l

1.18

226

982

Viral infections characterized by skin and mucous membrane lesions

186

927

2.01

17.86

1.7

1.6

19.63

24.55

umol/l

1.84

179

887

Nerve, nerve root and plexus disorders

395

1476

1.64

17.82

1.4

1.5

20.47

26.59

umol/l

4.09

374

1402

GI-bleeding

115

472

2.45

17.82

2.3

1.4

16.35

24.41

umol/l

3.17

108

453

Hypothyroidism, strict autoimmune, 3 medication purchases required

336

1334

1.71

17.79

1.4

1.5

24.03

25.46

umol/l

0.37

319

1271

Soft tissue disorders

408

1283

1.64

17.65

1.5

1.6

23.90

24.96

umol/l

0.28

392

1225

Polycystic ovarian syndrome, consortium definition

331

1146

1.72

17.45

1.5

1.4

22.45

26.67

umol/l

1.77

308

1091

Psoriasis

128

558

2.31

17.37

1.3

1.5

18.71

25.84

umol/l

2.38

122

533

Other and unspecified effects of external causes

144

660

2.19

17.33

1.6

23.25

24.63

umol/l

0.22

134

630

Asthma, unspecified (mode)

197

750

1.98

17.28

1.7

1.4

22.08

27.17

umol/l

1.59

187

709

Other intervertebral disc disorders

297

1019

1.76

17.14

1.6

1.4

20.24

26.77

umol/l

3.65

287

970

Other systemic involvement of connective tissue

125

543

2.31

17.11

1.8

1.4

21.74

25.41

umol/l

0.70

119

513

Dyspnoea

340

1505

1.67

17.11

1.5

23.57

25.55

umol/l

0.56

318

1434

Fissure and fistula of anal and rectal regions

102

405

2.53

17.01

1.9

1.4

17.96

26.42

umol/l

2.56

387

Other acute lower respiratory infections

213

1076

1.89

16.99

2.0

1.5

21.47

24.55

umol/l

0.85

204

1021

Acute sinusitis

222

1106

1.86

16.83

1.8

1.5

22.97

25.24

umol/l

0.54

211

1054

Selective serotonin reuptake inhibitors

360

1129

1.67

16.67

1.6

1.5

20.40

26.35

umol/l

3.58

340

1079

Diseases of the musculoskeletal system and connective tissue

244

657

1.87

16.35

1.6

1.7

23.55

26.01

umol/l

0.59

235

627

Syncope and collapse

141

558

2.17

16.12

1.7

1.4

20.60

26.81

umol/l

1.76

134

528

Epilepsy

129

581

2.22

16.09

2.2

1.7

17.82

24.17

umol/l

2.32

124

556

Missing teeth due to accident, extraction or parodontitis

208

1050

1.87

16.05

1.4

1.5

17.28

25.96

umol/l

5.31

193

997

Behavioural syndromes associated with physiological disturbances and physical factors

367

1615

1.61

16.00

1.5

24.55

24.77

umol/l

0.05

347

1541

Concussion

194

826

1.92

15.84

1.9

1.5

21.79

27.45

umol/l

1.93

181

794

Exclusions for E4_PCOS_CONSORTIUM

331

1250

1.66

15.80

1.7

1.5

23.87

25.35

umol/l

0.39

317

1195

Molar incisor enamel hypoplasia, with caries

7.32

15.80

2.1

2.8

15.91

14.83

umol/l

0.14

Continuous positive airway pressure

241

2.81

15.78

1.7

17.71

30.08

umol/l

3.60

234

Generalized anxiety disorder

344

2.60

15.74

1.6

1.5

25.75

24.70

umol/l

0.12

332

Cholecystectomy

265

1323

1.73

15.61

1.8

1.4

20.97

26.21

umol/l

2.36

260

1249

Hypertension, essential

298

986

1.71

15.60

1.5

20.82

28.12

umol/l

4.07

287

936

Asthma-related pneumonia

141

668

2.11

15.55

2.0

1.5

19.71

24.33

umol/l

1.30

134

639

Asthma-related pneumonia or sepsis

141

669

2.11

15.49

2.0

1.5

19.71

24.31

umol/l

1.29

134

640

Asthma, hospital admissions 3, pneumonia

141

669

2.11

15.49

2.0

1.5

19.71

24.31

umol/l

1.29

134

640

Fall on same level

454

1614

1.54

15.33

1.6

20.86

25.80

umol/l

3.21

432

1541

Cough

164

781

1.99

15.29

1.5

1.6

25.33

23.58

umol/l

0.29

153

750

Intracranial trauma

222

853

1.83

15.28

1.8

1.5

20.53

27.21

umol/l

2.96

208

820

Bleeding

289

1216

1.69

15.21

1.9

1.4

18.76

25.67

umol/l

4.40

276

1149

Symptoms and signs involving the urinary system

267

1184

1.72

15.10

1.7

1.5

19.80

25.78

umol/l

3.00

252

1122

Dental operations

210

568

1.90

15.05

1.4

1.5

21.20

30.07

umol/l

3.65

198

540

Chronic diseases of tonsils and adenoids

313

1192

1.66

15.03

1.4

1.6

26.61

24.45

umol/l

0.55

296

1134

Personality disorders

133

627

2.13

14.98

1.5

20.80

25.93

umol/l

1.33

126

599

Sleep disorders

347

1564

1.61

14.92

1.4

1.5

25.19

25.10

umol/l

0.02

327

1490

Benign neoplasms

376

1302

1.59

14.87

1.6

1.5

23.49

24.65

umol/l

0.30

362

1244

Asthma (diagnoses ohter than nonallergic)

340

1764

1.60

14.80

1.7

1.5

22.88

24.82

umol/l

0.60

324

1680

Other heart diseases, wide

372

1435

1.59

14.79

1.5

1.6

24.65

25.75

umol/l

0.27

354

1375

Eating disorder

237

2.89

14.67

1.7

1.6

20.24

23.40

umol/l

0.42

228

Disorders of thyroid, IBD co-morbidities

193

2.82

14.59

1.4

33.18

29.56

umol/l

0.34

188

Allergic rhinitis

158

794

1.98

14.49

1.4

1.7

26.00

23.59

umol/l

0.45

152

762

Antihypertensive medication - note that there are other indications

291

912

1.70

14.46

1.6

1.7

23.30

25.94

umol/l

0.77

277

870

Other joint disorders

358

1181

1.60

14.30

1.5

1.6

23.14

26.19

umol/l

1.07

340

1129

Non-selective monoamine reuptake inhibitors

132

609

2.10

14.20

1.5

1.4

18.68

27.26

umol/l

3.28

126

577

Coagulation defects, purpura and other haemorrhagic conditions

406

2.38

14.07

1.9

1.5

14.95

23.56

umol/l

3.60

387

Disorders of adult personality and behaviour

139

683

2.04

14.06

1.4

1.5

20.40

25.62

umol/l

1.47

132

654

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

184

610

1.91

14.05

1.7

1.4

21.88

30.02

umol/l

3.01

179

581

Other gastritis (incl. Duodenitis)

346

2.50

14.04

2.0

1.4

15.05

24.80

umol/l

3.95

330

Other viral diseases

145

722

2.01

14.01

2.0

1.7

23.97

23.27

umol/l

0.10

139

691

Eating disorders

272

2.70

13.92

1.7

1.6

19.61

24.75

umol/l

0.87

262

Disorders of conjunctiva

336

1708

1.58

13.86

1.4

1.6

25.68

24.27

umol/l

0.37

321

1627

Dermatophytosis

224

1288

1.74

13.85

1.4

1.5

24.73

25.17

umol/l

0.07

210

1229

Acute tubulo-interstitial nephritis

234

1170

1.73

13.80

1.7

1.4

17.61

26.35

umol/l

6.59

222

1112

Diseases of liver

135

662

2.05

13.73

1.8

1.5

16.97

26.00

umol/l

4.09

130

630

Chronic lower respiratory diseases

460

1640

1.50

13.65

1.7

1.5

22.14

25.31

umol/l

1.50

439

1560

Conjunctivitis

314

1646

1.60

13.55

1.4

1.6

26.22

24.51

umol/l

0.45

300

1568

Acute bronchitis

157

799

1.93

13.54

2.0

1.6

19.34

24.05

umol/l

1.47

152

766

Asthma/COPD (KELA code 203)

369

1638

1.55

13.46

1.7

1.5

22.93

25.32

umol/l

0.84

352

1558

Deforming dorsopathies

115

537

2.15

13.32

1.2

1.5

24.94

25.67

umol/l

0.09

109

511

Arthropathies

367

1190

1.57

13.24

1.6

22.86

26.14

umol/l

1.22

352

1138

Falls/tendency to fall

422

1395

1.52

13.23

1.6

1.5

20.68

26.66

umol/l

4.08

403

1335

Dizziness and giddiness

267

1282

1.65

13.19

1.5

1.4

27.43

25.76

umol/l

0.35

249

1221

Shoulder lesions

255

913

1.70

13.12

1.3

1.5

23.45

26.48

umol/l

0.83

240

867

Fibromyalgia

194

2.97

12.92

1.5

23.60

25.56

umol/l

0.17

183

Other medical care

152

710

1.93

12.91

1.5

1.4

37.96

24.90

umol/l

3.85

143

665

Other symptoms and signs involving cognitive functions and awareness

149

702

1.94

12.83

1.6

1.5

17.38

25.74

umol/l

3.93

141

667

Other external causes of accidental injury

320

1000

1.61

12.83

1.7

1.5

23.55

27.25

umol/l

1.26

303

956

Type 2 diabetes, wide definition

258

989

1.67

12.80

1.4

16.79

27.11

umol/l

8.81

239

938

Excessive, frequent and irregular menstruation

172

495

1.91

12.75

1.5

1.4

21.46

26.56

umol/l

1.44

159

472

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

383

2.34

12.60

1.6

1.5

26.69

24.46

umol/l

0.27

366

Other local infections of skin and subcutaneous tissue

181

3.01

12.57

2.4

1.5

13.77

25.45

umol/l

3.47

171

Gingivitis and periodontal diseases

370

1241

1.54

12.55

1.5

20.46

26.64

umol/l

3.87

346

1186

Urticaria

142

733

1.95

12.55

1.7

1.5

18.96

25.95

umol/l

2.76

135

703

Ulcerative colitis (strict definition, require KELA)

353

2.39

12.55

1.5

27.62

24.85

umol/l

0.32

338

Chronic apical periodontitis

410

1561

1.50

12.48

1.6

1.5

18.36

26.68

umol/l

8.32

382

1495

Lichen ruber planus, wide definition including periferal and oral lichen planus

411

2.27

12.38

1.3

1.4

24.84

25.85

umol/l

0.11

392

Polyarthropathies

247

966

1.67

12.35

1.5

1.6

20.45

27.31

umol/l

3.16

231

923

Nonorganic sleeping disorders

102

469

2.19

12.34

1.5

1.6

24.23

24.87

umol/l

0.07

446

Adverse effects, not elsewhere classified

103

477

2.17

12.25

1.7

1.6

19.68

24.07

umol/l

0.97

453

Other neurological diseases

236

1111

1.67

12.20

1.6

1.5

22.00

25.62

umol/l

1.08

224

1052

Cystitis

321

1219

1.57

12.16

1.7

1.4

23.03

25.96

umol/l

0.99

305

1160

Disturbances of skin sensation

120

591

2.04

12.14

1.7

1.5

28.81

25.36

umol/l

0.50

112

564

Inflammatory diseases of female pelvic organs

266

1207

1.62

12.11

1.5

1.4

21.81

26.68

umol/l

2.03

254

1141

Cardiac arrhythmias

236

912

1.69

12.10

1.4

1.5

26.24

27.51

umol/l

0.23

225

879

Diseases of the ear and mastoid process

435

1480

1.48

12.08

1.6

1.5

24.82

25.05

umol/l

0.05

424

1404

Disease of hard tissues of teeth, NOS

183

521

1.84

12.06

1.6

1.4

21.00

29.78

umol/l

3.30

168

499

Benign neoplasm: Colon

166

870

1.83

12.04

1.6

1.4

22.93

25.13

umol/l

0.42

160

816

Menorrhagia

151

430

1.96

12.04

1.3

1.5

25.42

27.08

umol/l

0.24

138

409

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

348

2.37

12.01

1.5

27.25

24.79

umol/l

0.28

333

Herpesviral [herpes simplex] infections

116

567

2.06

11.99

1.4

1.6

22.62

25.31

umol/l

0.46

109

537

Diseases of the eye and adnexa

314

994

1.59

11.98

1.6

25.62

24.76

umol/l

0.18

297

952

Insomnia

332

1578

1.54

11.91

1.3

1.5

25.73

24.97

umol/l

0.17

313

1500

Asthma, including avohilmo

438

1683

1.46

11.89

1.6

1.5

23.14

24.85

umol/l

0.57

415

1605

Lumbar disc prolapse

215

970

1.70

11.86

1.6

1.4

21.00

27.09

umol/l

2.51

207

925

Sequelae with surgical and medical care as external cause

369

2.32

11.82

2.2

1.4

17.58

23.81

umol/l

1.41

352

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

212

1122

1.69

11.77

1.5

24.88

24.82

umol/l

0.01

200

1060

Haemorrhage from respiratory passages

108

464

2.10

11.71

1.9

1.6

22.93

24.76

umol/l

0.26

103

448

Diabetes mellitus

382

1495

1.50

11.66

1.6

1.5

20.81

26.23

umol/l

3.18

359

1432

Zoster [herpes zoster]

166

911

1.80

11.53

1.3

1.5

23.75

26.44

umol/l

0.55

157

861

Other viral diseases

170

949

1.78

11.49

1.8

1.6

24.16

24.05

umol/l

0.02

164

912

Spondylosis

166

749

1.81

11.44

1.4

23.79

27.18

umol/l

0.73

156

712

Sequelae of external causes of morbidity and mortality

102

485

2.11

11.36

2.1

1.5

17.45

24.76

umol/l

2.13

464

Spinal stenosis

146

588

1.89

11.36

1.3

19.46

27.87

umol/l

2.97

140

554

Malignant neoplasm, wide definition for exclusion

318

1208

1.55

11.33

1.5

32.85

22.98

umol/l

4.98

304

1152

Other and unspecified local infections of skin and subcutaneous tissue

176

2.92

11.32

2.5

1.5

13.89

25.90

umol/l

3.38

166

Exposure to other specified factors

284

1676

1.56

11.32

1.5

21.95

24.91

umol/l

0.98

271

1596

Functional dyspepsia

107

519

2.07

11.31

1.5

1.4

25.15

26.13

umol/l

0.12

101

493

Specific personality disorders

111

546

2.04

11.31

1.5

20.81

25.79

umol/l

1.15

105

523

Diabetes, varying definitions

379

1496

1.49

11.29

1.6

1.5

20.87

26.23

umol/l

3.10

357

1432

Colonic or urogenital fistula

108

527

2.06

11.24

1.8

1.5

17.54

25.58

umol/l

2.71

102

503

Type 2 diabetes

348

1346

1.51

11.23

1.4

1.5

20.61

27.07

umol/l

3.88

325

1289

Misadventures to patients during surgical and medical care

245

2.59

11.14

1.9

1.3

22.98

26.37

umol/l

0.34

233

Liquid cancers, helper endpoint

119

522

1.99

11.11

1.5

29.26

21.71

umol/l

1.54

114

494

Diseases of salivary glands

130

681

1.92

11.07

1.6

1.5

26.54

25.76

umol/l

0.10

123

650

Abnormal findings on examination of blood, without diagnosis

152

766

1.83

11.01

1.8

1.5

19.84

23.80

umol/l

1.11

147

733

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

230

1380

1.62

11.01

1.4

1.5

27.19

25.33

umol/l

0.39

219

1311

Accidents

310

1000

1.56

10.97

1.7

1.5

23.77

27.25

umol/l

1.13

295

956

Asthma, hospital admissions , main diagnosis only

308

1789

1.52

10.96

1.6

1.5

22.32

24.78

umol/l

0.82

294

1705

Disorders of sclera, cornea, iris and ciliary body

196

1165

1.69

10.92

1.6

1.5

21.10

25.89

umol/l

1.60

184

1109

Benign neoplasm of colon, rectum, anus and anal canal

191

975

1.70

10.84

1.6

1.4

22.96

25.56

umol/l

0.58

185

915

Dentofacial anomalies [including malocclusion]

283

1469

1.55

10.83

1.4

1.6

25.58

25.27

umol/l

0.06

261

1405

Other diseases of pleura

133

616

1.90

10.78

1.6

1.5

21.10

23.80

umol/l

0.50

125

586

Type 2 diabetes, definitions combined

325

1257

1.52

10.76

1.5

1.4

20.07

27.34

umol/l

4.68

308

1200

Presence of other functional implants

172

675

1.77

10.72

1.5

1.3

23.40

25.23

umol/l

0.31

156

638

Allergic conjunctivitis

239

1462

1.60

10.69

1.4

1.5

26.65

25.23

umol/l

0.29

227

1390

Unspecified fall

182

1051

1.71

10.67

1.7

1.6

17.15

24.54

umol/l

4.29

175

1003

Substance abuse

196

1099

1.68

10.67

1.8

1.5

14.04

26.12

umol/l

15.50

189

1048

Hernia

326

1452

1.51

10.64

1.8

1.4

21.35

25.99

umol/l

2.12

314

1373

Type 2 diabetes, strict (exclude DM1)

326

1271

1.51

10.42

1.5

19.77

27.25

umol/l

5.02

309

1213

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

323

1378

1.50

10.35

1.6

1.4

21.91

26.33

umol/l

1.91

314

1298

External causes of morbidity and mortality

250

780

1.61

10.23

1.7

1.5

23.03

27.74

umol/l

1.56

240

745

Lichen planus, including avohilmo

344

2.25

10.08

1.3

1.4

22.41

25.94

umol/l

0.48

326

Deviated nasal septum

106

535

1.99

10.06

1.4

1.5

25.57

23.88

umol/l

0.21

101

514

Convalescence

3.68

9.98

1.4

1.3

16.21

27.71

umol/l

1.67

Disorders of ocular muscles, binocular movement, accommodation and refraction

191

1146

1.66

9.97

1.8

1.6

22.35

24.91

umol/l

0.61

184

1097

All influenza (not pneumonia)

265

2.43

9.96

2.1

1.5

18.87

25.31

umol/l

1.12

253

Mental and behavioural disorders due to psychoactive substance use

199

1127

1.64

9.89

1.8

1.5

14.62

26.14

umol/l

12.70

192

1074

Tonsillectomy and adenotomy

255

1141

1.56

9.81

1.6

1.7

23.48

24.63

umol/l

0.26

243

1093

Ovarian cyst

148

471

1.82

9.69

1.5

1.4

22.67

26.56

umol/l

0.83

140

448

Procreative management

156

746

1.75

9.69

2.1

1.6

25.52

23.86

umol/l

0.28

151

721

Diverticular disease of intestine

201

779

1.65

9.63

1.4

1.3

22.18

26.70

umol/l

1.34

193

739

Caries of enamel

332

1642

1.46

9.48

1.6

1.5

25.30

24.33

umol/l

0.22

321

1555

Injury, poisoning and certain other consequences of external causes

213

652

1.64

9.46

1.7

1.5

22.97

26.93

umol/l

1.08

205

624

Injuries to the knee and lower leg

426

1684

1.41

9.42

1.6

1.5

22.71

25.19

umol/l

0.96

405

1603

Other arthrosis

169

686

1.71

9.40

1.3

1.5

19.38

29.00

umol/l

4.40

161

658

Injuries to the abdomen, lower back, lumbar spine and pelvis

138

770

1.78

9.34

1.8

1.5

18.43

24.72

umol/l

2.21

132

731

Erosion of teeth , including avohilmo

111

586

1.90

9.32

1.8

1.6

22.90

24.47

umol/l

0.22

106

557

Rotator cuff syndrome

186

806

1.66

9.31

1.3

1.4

20.37

26.90

umol/l

2.58

175

766

Reimbursement for rheumatic diseases

201

1251

1.60

9.27

1.4

1.5

20.11

26.05

umol/l

2.31

191

1188

Rheumatism, unspecified

244

2.43

9.25

1.6

1.5

20.96

27.65

umol/l

0.99

229

Haemorrhoids and perianal venous thrombosis

485

1.98

9.10

1.3

26.86

26.29

umol/l

0.06

459

Other arrhythmias

220

1059

1.57

8.92

1.4

1.5

24.06

27.14

umol/l

0.78

208

1009

Temporomandibular joint disorders, including avohilmo

184

1123

1.62

8.85

1.3

1.5

26.29

25.38

umol/l

0.14

171

1074

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

135

771

1.76

8.81

1.5

29.17

25.08

umol/l

0.71

129

736

Type 2 diabetes, definitions combined, including avohilmo

322

1289

1.46

8.77

1.5

19.74

27.21

umol/l

4.99

305

1231

Other diseases of blood and blood-forming organs, wide

425

2.03

8.76

1.7

1.5

20.20

24.85

umol/l

0.86

405

Exfoliative dermatitis

14.45

8.75

1.2

1.5

11.46

19.01

umol/l

—

Migraine with aura

106

565

1.88

8.67

1.4

1.5

20.04

26.62

umol/l

1.71

540

STROKE

176

725

1.65

8.66

1.4

1.5

22.42

28.56

umol/l

1.82

166

691

Triptan medication for migraine, single purchase ok

298

1380

1.47

8.60

1.5

27.82

25.16

umol/l

0.72

288

1306

Migraine, single triptan purchase ok & required. ICD-code if available is included

298

1380

1.47

8.60

1.5

27.82

25.16

umol/l

0.72

288

1306

Triptan medication for migraine, min. 3 purchases

238

1191

1.53

8.59

1.6

1.5

25.88

26.08

umol/l

0.03

231

1132

Insulin medication

190

999

1.60

8.57

1.7

1.6

18.49

25.74

umol/l

3.30

176

952

Insulin, combination of fast acting with intermediate-acting or long-acting

190

1091

1.59

8.50

1.7

1.5

18.49

24.82

umol/l

2.70

176

1042

Glomerular diseases

331

2.16

8.45

1.5

1.6

12.06

23.66

umol/l

6.32

315

Symptoms and signs involving speech and voice

118

658

1.80

8.38

1.3

1.5

26.68

25.24

umol/l

0.19

112

628

Other congenital malformations of the digestive system

121

2.99

8.37

4.0

2.1

23.44

20.34

umol/l

0.25

116

Injuries to the hip and thigh

147

788

1.69

8.33

1.9

1.5

14.47

25.24

umol/l

8.38

139

750

Intracranial injury

198

1196

1.57

8.32

1.9

1.5

19.36

24.81

umol/l

2.37

184

1146

Heart failure,strict

136

549

1.75

8.32

1.4

1.5

15.05

28.02

umol/l

7.41

130

518

Chronic periodontitis, including avohilmo

312

1453

1.44

8.27

1.4

1.5

19.65

26.69

umol/l

4.62

292

1383

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

102

3.17

8.23

1.2

1.4

22.72

21.96

umol/l

0.05

Other congenital malformations of the digestive system

144

2.79

8.22

3.7

2.1

24.16

19.55

umol/l

0.44

138

Amenorrhoea

162

2.68

8.22

2.1

1.6

16.57

26.10

umol/l

1.71

155

Impingement syndrome of shoulder

395

2.03

8.20

1.4

1.5

24.89

27.98

umol/l

0.38

376

Diseases of arteries, arterioles and capillaries

185

855

1.60

8.16

1.6

1.4

18.23

25.36

umol/l

3.13

180

808

Periodontitis

312

1455

1.44

8.12

1.4

1.5

19.35

26.74

umol/l

5.13

292

1385

Insulin, intermediate and long-acting

167

1004

1.62

8.07

1.7

1.6

19.37

24.67

umol/l

1.69

154

959

Abnormal findings on diagnostic imaging of lung

135

759

1.71

8.00

1.4

25.78

25.15

umol/l

0.08

126

717

Diseases of pulp and periapical tissues and dental caries

224

742

1.55

8.00

1.5

20.73

29.03

umol/l

3.92

214

711

Heart failure, strict

148

619

1.69

7.99

1.3

1.5

15.22

26.04

umol/l

6.01

141

587

Dental caries, including avohilmo

244

824

1.52

7.93

1.6

1.5

20.75

28.67

umol/l

3.91

231

787

Other and unspecified rosacea

154

2.68

7.89

1.4

1.5

18.09

26.97

umol/l

1.43

145

Malignant neoplasm

286

1164

1.46

7.85

1.6

1.5

34.40

22.96

umol/l

5.72

274

1109

Lichen planus

220

2.38

7.82

1.2

1.4

19.75

24.96

umol/l

0.68

205

Noninflammatory disorders of female genital tract

167

508

1.65

7.75

1.6

1.5

23.74

26.31

umol/l

0.51

161

485

Solid cancers, helper endpoint

279

1136

1.45

7.57

1.5

34.10

23.11

umol/l

5.26

267

1082

Retention of urine

387

1.91

7.55

1.8

1.4

17.50

24.18

umol/l

1.70

370

Diseases of middle ear and mastoid

216

1173

1.51

7.51

1.7

1.5

22.70

24.57

umol/l

0.43

205

1124

Endometriosis

134

458

1.72

7.46

1.4

28.32

26.76

umol/l

0.20

122

435

Subjective visual disturbances

522

1.85

7.46

1.5

27.36

25.28

umol/l

0.25

505

Congenital malformations, deformations and chromosomal abnormalities

243

1530

1.47

7.46

1.7

1.5

23.24

24.86

umol/l

0.37

230

1463

Other cataract

135

606

1.69

7.42

1.4

1.5

20.49

26.17

umol/l

1.40

127

568

Endometriosis of pelvic peritoneum

326

2.06

7.37

1.4

27.64

28.16

umol/l

0.04

310

Internal derangement of knee

122

711

1.71

7.36

1.4

1.5

25.64

27.93

umol/l

0.33

109

678

Benign neoplasm of other and ill-defined parts of digestive system

311

2.10

7.30

1.6

1.4

18.27

25.00

umol/l

1.21

298

All-cause Heart Failure

143

609

1.66

7.29

1.3

1.5

15.27

26.15

umol/l

5.77

136

577

Other immunodeficiencies

7.52

7.25

2.4

1.5

27.64

16.06

umol/l

0.64

Impetigo

100

3.03

7.20

1.5

1.7

18.11

25.01

umol/l

0.80

Cervicocranial syndrome

187

2.42

7.07

1.6

1.4

26.52

23.71

umol/l

0.20

177

Other and unspecified urticaria

476

1.86

6.99

1.7

1.5

15.66

24.46

umol/l

4.38

455

Other disorders of ear

300

1401

1.40

6.95

1.5

22.97

25.22

umol/l

0.65

287

1329

Diabetes medication

357

1550

1.37

6.95

1.5

20.84

26.17

umol/l

2.97

336

1481

Congenital malformations, deformations and chromosomal abnormalities

220

1427

1.47

6.93

1.8

1.5

22.86

24.77

umol/l

0.44

210

1363

Dermatitis due to substances taken internally

3.20

6.84

1.7

1.5

13.99

22.12

umol/l

1.28

Hard cardiovascular diseases

272

1137

1.43

6.84

1.4

1.6

22.33

26.09

umol/l

1.24

253

1086

Other shoulder lesions

178

2.43

6.83

1.5

1.4

25.93

25.52

umol/l

0.03

167

Diseases of inner ear

165

1027

1.56

6.83

1.4

25.34

25.55

umol/l

0.03

154

975

Nasal polyp

306

2.07

6.82

1.5

28.60

25.40

umol/l

0.30

293

Other inflammatory liver diseases

109

2.87

6.79

1.9

1.3

15.16

27.47

umol/l

2.17

102

Other (not insulin) diabetes medications

311

1330

1.39

6.68

1.4

20.17

27.13

umol/l

4.21

292

1267

Postviral fatigue syndrome

12.59

6.63

1.2

1.0

20.75

20.74

umol/l

—

Disorders of refraction and accommodation

115

683

1.68

6.56

1.9

1.6

20.87

24.05

umol/l

0.62

109

655

Unspecified haematuria

112

547

1.70

6.48

2.0

1.5

17.03

25.07

umol/l

2.81

105

524

Gonarthrosis

194

732

1.51

6.46

1.3

1.5

21.26

28.61

umol/l

2.79

187

702

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

305

1330

1.38

6.43

1.6

1.5

19.11

26.66

umol/l

5.12

282

1273

Explicit bacterial Sepsis

153

2.49

6.41

2.1

1.4

20.24

23.99

umol/l

0.35

146

Disorders of synovium and tendon

171

984

1.52

6.39

1.4

1.5

24.22

26.47

umol/l

0.42

160

935

Fall on same level involving ice and snow

185

1243

1.49

6.34

1.6

1.4

20.26

25.83

umol/l

2.11

174

1179

Carpal tunnel syndrome

193

1149

1.48

6.33

1.4

19.41

27.11

umol/l

3.91

187

1090

Insulin, fast-acting

120

731

1.64

6.30

1.8

1.6

16.25

23.98

umol/l

3.31

112

702

Agranulocytosis

211

2.24

6.25

1.6

1.4

21.43

24.45

umol/l

0.31

199

Streptococcal septicaemia

120

2.68

6.24

2.1

1.3

19.16

23.80

umol/l

0.42

115

Rosacea

231

2.18

6.20

1.3

1.5

21.43

26.26

umol/l

0.61

219

Keratitis

120

736

1.63

6.17

1.6

1.5

19.56

25.92

umol/l

1.81

114

704

Special screening examination for other diseases and disorders

144

2.51

6.16

1.5

1.3

23.01

27.00

umol/l

0.32

138

Phlebitis and thrombophlebitis (not including DVT)

424

1.85

6.15

1.7

1.4

19.93

25.45

umol/l

1.01

403

Disorders of vestibular function (Vertigo)

142

893

1.57

6.12

1.4

1.5

26.64

25.03

umol/l

0.23

132

849

Other abnormal uterine and vaginal bleeding

315

1.85

6.04

1.3

1.4

16.78

25.99

umol/l

2.59

297

Any event in cancer register

313

1354

1.36

6.03

1.5

34.09

22.65

umol/l

6.32

297

1291

Gonarthrosis [arthrosis of knee](FG)

217

869

1.45

6.03

1.3

1.5

21.05

27.73

umol/l

2.71

209

827

Dental pulpitis, including avohilmo

321

1542

1.35

6.01

1.6

1.5

21.31

25.88

umol/l

2.21

305

1471

Other sleep disorders

183

2.31

6.00

1.4

25.06

26.43

umol/l

0.09

174

Varicose veins

180

913

1.49

5.95

1.5

1.3

20.67

26.44

umol/l

1.97

173

856

Unspecified mental disorder

139

893

1.56

5.90

1.5

23.28

25.97

umol/l

0.51

131

856

Viral warts

503

1.76

5.90

1.6

22.88

23.96

umol/l

0.13

480

Insulin, fast-acting or short human

120

747

1.61

5.82

1.8

1.6

16.25

24.01

umol/l

3.35

112

716

In situ neoplasms

116

720

1.61

5.72

1.3

1.4

24.51

25.40

umol/l

0.11

106

684

Suppurative and unspecified otitis media

142

816

1.55

5.70

1.8

1.6

20.10

23.89

umol/l

0.97

134

782

Other and unspecified tonsillitis

126

668

1.59

5.67

2.0

1.6

21.56

24.69

umol/l

0.61

119

641

Injuries to the elbow and forearm

240

1518

1.39

5.64

1.6

1.5

22.98

24.99

umol/l

0.49

227

1447

Ischemic heart diseases

255

1102

1.39

5.63

1.3

1.6

22.45

25.93

umol/l

1.05

235

1052

Non-allergic asthma (mode), excluding more controls

292

1.97

5.61

1.8

1.5

20.62

25.42

umol/l

0.65

278

Arthrosis

217

832

1.43

5.57

1.4

1.5

19.82

28.17

umol/l

4.17

208

793

Other arthritis (FG)

587

1.67

5.57

1.3

1.6

22.49

26.82

umol/l

0.79

563

Transport accidents

146

824

1.53

5.55

1.5

17.98

26.93

umol/l

4.46

140

788

Caries of dentine, including avohilmo

257

945

1.39

5.51

1.5

1.6

20.01

28.70

umol/l

5.10

243

904

Pleural effusion

210

2.15

5.48

1.6

1.4

28.58

22.75

umol/l

0.50

200

Telogen effluvium

12.67

5.46

1.1

1.0

18.42

21.86

umol/l

—

Diabetes, insulin treatment (Kela reimbursement)

320

1451

1.33

5.44

1.6

1.5

19.05

26.67

umol/l

5.48

295

1388

Sequelae of injuries of head

2.97

5.42

1.2

1.3

15.14

27.41

umol/l

1.77

Conduction disorders

373

1.76

5.39

1.3

1.6

26.57

26.85

umol/l

0.02

356

Other postsurgical states

112

2.61

5.38

2.3

1.7

10.54

23.55

umol/l

4.87

106

Other extrapyramidal and movement disorders in other diseases

439

1.76

5.25

1.3

1.5

23.80

24.55

umol/l

0.08

417

Problems related to lifestyle

169

2.26

5.22

1.5

1.3

11.63

26.26

umol/l

7.87

163

Chronic periodontitis, complicated

155

1045

1.47

5.09

1.4

1.5

19.97

26.07

umol/l

2.11

148

989

Diseases of pulp and periapical tissues, including avohilmo

350

1388

1.31

5.07

1.6

1.5

21.12

26.70

umol/l

3.10

326

1332

Redundant prepuce, phimosis and paraphimosis

297

1.90

5.03

2.0

1.7

10.87

25.31

umol/l

12.20

283

Other and unspecified mental retardation

3.21

5.02

2.8

2.4

12.26

17.15

umol/l

1.23

Bipolar affective disorders

402

1.77

4.98

1.3

1.5

17.88

28.51

umol/l

3.22

387

Injuries to the shoulder and upper arm

256

1535

1.34

4.88

1.4

1.5

19.48

25.58

umol/l

3.32

244

1455

Mouth breathing

128

845

1.52

4.87

1.6

26.90

23.89

umol/l

0.48

122

807

Non-rheumatic valve diseases

123

575

1.55

4.87

1.3

1.6

19.51

27.17

umol/l

2.30

114

545

Dipeptidyl peptidase 4 (DPP-4) inhibitors

139

744

1.50

4.84

1.2

1.5

16.09

26.10

umol/l

5.26

128

703

Disorders of phosphorus metabolism and phosphatases

9.41

4.84

4.8

1.7

18.61

27.47

umol/l

—

Injuries to the ankle and foot

247

1633

1.35

4.80

1.4

1.6

23.10

24.54

umol/l

0.34

235

1556

Disorders of breast

182

1171

1.41

4.78

1.3

1.4

25.64

26.30

umol/l

0.11

175

1104

Acute suppurative otitis media

107

636

1.57

4.77

2.0

1.7

19.82

23.52

umol/l

0.79

101

608

Digestive system disorders of fetus and newborn

16.24

4.74

7.1

1.6

11.27

11.12

umol/l

—

Certain conditions originating in the perinatal period

215

1.99

4.72

3.0

1.9

19.25

21.08

umol/l

0.19

207

Excessive attrition of teeth

191

1374

1.39

4.67

1.4

1.5

20.97

25.22

umol/l

1.37

179

1309

Iridocyclitis

448

1.70

4.66

1.4

1.5

21.84

24.94

umol/l

0.40

428

Conductive and sensorineural hearing loss

224

1106

1.37

4.66

1.5

25.42

25.38

umol/l

0.01

212

1047

Oral lichen planus, including avohilmo , including avohilmo

121

2.41

4.64

1.3

1.5

25.60

24.32

umol/l

0.08

112

Rheumatoid arthritis

532

1.60

4.59

1.3

1.4

23.27

29.61

umol/l

1.19

509

Biguanides

285

1318

1.32

4.59

1.5

18.47

27.21

umol/l

6.68

267

1252

Non-allergic asthma (mode)

314

1.83

4.59

1.8

1.5

20.62

25.16

umol/l

0.60

297

Restless leg syndrome

261

1.92

4.57

1.3

1.5

27.50

23.94

umol/l

0.31

247

Obsessive-compulsive disorder

141

2.28

4.54

1.9

1.5

33.66

25.53

umol/l

0.64

135

Disorders of lens

188

836

1.41

4.54

1.5

1.4

23.06

26.92

umol/l

0.94

181

788

Gout

291

1.82

4.54

1.6

1.5

18.69

26.99

umol/l

1.35

278

Sulfasalazine

513

1.64

4.51

1.5

16.48

25.71

umol/l

3.13

495

Pyoderma gangrenosum

6.86

4.50

1.5

1.2

29.60

17.46

umol/l

—

Primary biliary cholangitis (PBC)

5.28

4.47

1.2

1.3

15.58

29.34

umol/l

0.81

Valvular heart disease excluding rheumatic fever

124

594

1.51

4.44

1.3

1.6

19.47

26.82

umol/l

2.19

115

564

Complications of internal orthopaedic prosthetic devices, implants and grafts

329

1.80

4.40

1.5

1.3

13.90

26.20

umol/l

4.35

313

Extrapyramidal and movement disorders

105

681

1.54

4.40

1.2

1.5

25.30

23.95

umol/l

0.17

646

Birth asphyxia

5.75

4.35

3.6

2.0

13.95

12.06

umol/l

0.64

Acute and subacute iridocyclitis

382

1.73

4.35

1.5

21.90

24.63

umol/l

0.31

364

Other congenital malformations of intestine

5.65

4.32

8.3

1.4

26.20

19.40

umol/l

0.29

Degeneration of macula and posterior pole

106

549

1.54

4.24

1.3

1.4

25.57

25.45

umol/l

0.01

521

Isolated growth hormone deficiency

4.51

4.19

2.8

2.7

15.32

15.50

umol/l

0.02

Coxibs

264

1.66

4.16

1.7

1.6

20.41

22.97

umol/l

0.35

250

Maltreatment syndromes

115

2.36

4.16

1.7

1.5

27.55

27.03

umol/l

0.03

109

Anterior Iridocyclitis

419

1.68

4.11

1.5

21.29

24.48

umol/l

0.41

399

Other disorders of carbohydrate metabolism

8.32

4.10

5.4

1.7

13.89

12.74

umol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

193

1310

1.36

4.09

1.6

1.5

21.86

25.81

umol/l

1.19

184

1249

Fracture of lower leg, including ankle

163

1158

1.40

4.09

1.5

23.28

25.99

umol/l

0.58

156

1097

Unspecified urinary incontinence

161

2.12

4.09

1.2

1.4

19.13

21.74

umol/l

0.21

151

Glucagon-like peptide-1 (GLP-1) analogues

567

1.57

4.07

1.4

1.5

25.58

27.63

umol/l

0.23

542

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

567

1.57

4.07

1.4

1.5

25.58

27.63

umol/l

0.23

542

Behçet disease

10.57

4.07

1.6

1.1

11.29

13.09

umol/l

—

Other menopausal disorders

337

1.58

3.93

1.6

1.4

25.39

27.39

umol/l

0.24

320

Other abnormal findings of blood chemistry

2.73

3.92

1.7

1.3

15.42

27.17

umol/l

1.38

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

138

610

1.44

3.88

1.4

1.5

25.96

24.84

umol/l

0.16

131

584

Congenital absence, atresia and stenosis of small intestine

13.54

3.87

6.0

1.2

12.47

29.04

umol/l

—

Benign paroxysmal vertigo

560

1.56

3.83

1.4

29.87

25.15

umol/l

0.62

530

Cerebrovascular diseases

191

993

1.35

3.81

1.5

1.4

17.63

25.86

umol/l

4.71

183

935

Unspecified/other endometriosis

200

1.96

3.81

1.6

1.5

24.06

27.14

umol/l

0.24

192

Hypoplasia of dental enamel, prenatal

6.30

3.80

2.3

2.6

13.54

11.29

umol/l

—

Sensorineural hearing loss

202

1024

1.34

3.78

1.6

1.5

25.60

25.39

umol/l

0.03

190

968

Alcohol use disorder, Swedish definition

146

956

1.40

3.77

1.8

1.5

16.04

25.29

umol/l

5.42

141

907

Acute generalized exanthematous pustulosis

2.66

3.73

1.7

1.4

14.67

27.02

umol/l

1.57

Gout, idiopatic and unspecified

318

1.73

3.69

1.6

1.4

18.09

22.91

umol/l

0.62

301

Defects in the complement system

5.78

3.69

2.9

1.2

29.62

17.31

umol/l

—

Congenital malformations and deformations of the musculoskeletal system

324

1.73

3.68

1.9

18.91

22.13

umol/l

0.45

310

Melanocytic naevi

654

1.50

3.67

1.4

1.5

26.28

25.17

umol/l

0.13

621

Presence of cardiac and vascular implants and grafts

428

1.55

3.67

1.2

1.4

22.57

24.19

umol/l

0.19

408

Other noninflammatory disorders of vagina

155

2.07

3.66

1.4

1.6

15.99

24.64

umol/l

1.50

147

Injuries to the head

359

1780

1.24

3.65

1.7

1.5

18.58

25.61

umol/l

5.93

333

1704

Gout, FINNGEN

356

1.68

3.64

1.6

1.4

18.69

23.86

umol/l

0.72

339

Localized swelling, mass and lump of skin and subcutaneous tissue

624

1.51

3.62

1.5

23.02

24.57

umol/l

0.19

601

Cutaneous lupus erythematosus

3.54

3.61

1.3

16.99

24.52

umol/l

0.51

Other congenital malformations of brain

4.97

3.61

2.8

1.9

12.29

15.99

umol/l

—

Disorders of choroid and retina

212

1148

1.31

3.51

1.5

20.49

25.81

umol/l

1.94

193

1093

Coronary revascularization (ANGIO or CABG)

222

1040

1.31

3.49

1.4

1.6

23.14

26.16

umol/l

0.75

204

993

ILD, hospital admission 2, with pulmonary infections

132

2.13

3.44

2.5

1.4

16.93

24.90

umol/l

0.85

126

Autoimmune hyperthyroidism

100

2.31

3.43

1.5

1.4

37.53

26.27

umol/l

0.68

Percutaneous Coronary Intervention

221

1040

1.30

3.40

1.4

1.6

23.71

26.16

umol/l

0.55

203

993

Flatulence and related conditions

7.10

3.37

2.3

1.3

12.00

26.20

umol/l

—

Other prurigo

7.10

3.37

2.4

1.4

12.11

18.78

umol/l

—

Other obstetric conditions, not elsewhere classified

138

631

1.39

3.31

1.4

1.6

26.61

25.08

umol/l

0.23

131

605

312

1.65

3.28

1.3

1.4

22.78

23.53

umol/l

0.07

295

Impaction of intestines

8.73

3.28

3.2

1.6

11.75

33.64

umol/l

—

Open wound of head

147

1041

1.36

3.28

1.6

16.46

24.70

umol/l

4.84

138

997

Other retinal disorders

157

904

1.35

3.27

1.5

22.48

25.22

umol/l

0.54

144

858

Artrosis, including avohilmo

250

1071

1.28

3.27

1.4

1.5

24.44

26.73

umol/l

0.53

240

1020

Follow-up examination after treatment for malignant neoplasms

2.34

3.24

1.2

1.3

17.59

30.48

umol/l

1.33

Other disorders of white blood cells

2.45

3.21

1.8

1.4

25.41

25.39

umol/l

0.00

Injuries to the neck

504

1.53

3.21

1.4

1.6

21.51

25.32

umol/l

0.54

479

Injury of nerves and spinal cord at thorax level

6.56

3.21

1.6

1.5

11.61

25.33

umol/l

—

Endometriosis ASRM stages 1,2

449

1.56

3.20

1.4

27.64

25.85

umol/l

0.18

429

DVT of lower extremities

302

1.69

3.19

2.1

1.3

24.31

25.19

umol/l

0.07

287

Unspecified visual impairment (binocular)

3.72

3.10

2.0

1.8

21.49

20.53

umol/l

0.03

Systemic disorders of connective tissue in diseases classified elsewhere

7.76

3.08

6.7

1.1

8.75

20.99

umol/l

—

Respiratory insufficiency

2.28

3.07

1.3

1.5

17.21

23.85

umol/l

0.61

Major coronary heart disease event

233

1104

1.27

3.06

1.4

1.5

22.78

25.61

umol/l

0.73

216

1053

Glucosamine medication

112

635

1.41

3.01

1.2

1.4

20.69

25.68

umol/l

1.15

105

595

Emergency coronary revascularization (for ACS)

231

1104

1.27

3.01

1.4

1.5

23.10

25.55

umol/l

0.58

213

1051

161

1071

1.32

2.99

1.8

1.5

16.39

25.85

umol/l

5.82

156

1020

Generalized skin eruption due to drugs and medicaments

2.48

2.96

1.8

1.4

15.12

27.79

umol/l

1.45

Common variable immunodeficiency

4.84

2.94

5.4

1.2

9.20

16.85

umol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

111

535

1.41

2.92

1.3

1.4

19.78

22.75

umol/l

0.54

103

502

Fracture of forearm

169

1190

1.30

2.81

1.7

1.5

25.49

26.00

umol/l

0.07

161

1131

Abrasion of teeth

104

744

1.40

2.81

1.5

27.59

25.57

umol/l

0.27

712

Other female pelvic inflammatory diseases

353

1.59

2.80

1.3

1.4

23.83

26.82

umol/l

0.28

333

Marasmic kwashiorkor

8.77

2.78

3.4

1.5

10.06

13.38

umol/l

—

Congenital absence, atresia and stenosis of large intestine

6.58

2.77

6.5

3.3

14.27

13.20

umol/l

—

Nosocomial condition (hospital)

8.49

2.76

1.0

1.2

11.90

12.80

umol/l

—

Precocious central puberty

8.48

2.76

3.8

1.7

29.64

11.22

umol/l

—

Sleep disorders, other/unspecified

2.32

2.75

2.1

1.6

23.80

27.56

umol/l

0.18

Disorders of vitreous body

129

926

1.35

2.74

1.4

27.18

26.25

umol/l

0.12

119

875

Panniculitis, unspecified

5.07

2.74

1.3

1.0

23.00

17.94

umol/l

—

Monosomies and deletions from the autosomes, not elsewhere classified

6.29

2.73

4.7

2.0

12.10

10.91

umol/l

—

Malignant melanoma, including Hilmo

240

1.71

2.73

1.3

32.72

22.22

umol/l

1.06

226

Juvenile cataract

6.19

2.72

1.5

1.1

39.50

12.23

umol/l

—

Other fall from one level to another

500

1.48

2.71

1.6

1.7

16.14

23.19

umol/l

2.14

485

Other and unspecified primary disorders of muscles

4.30

2.70

3.9

1.6

28.04

16.40

umol/l

—

Intentional self-harm by unspecified means

4.26

2.68

1.0

1.1

30.19

16.92

umol/l

—

Coronary atherosclerosis

153

734

1.32

2.68

1.3

1.5

18.76

25.81

umol/l

2.62

141

695

Rheumatoid arthritis, including avohilmo

104

751

1.39

2.67

1.3

1.4

22.24

26.00

umol/l

0.67

709

Infections with a predominantly sexual mode of transmission

140

986

1.32

2.66

1.3

1.6

26.08

25.40

umol/l

0.10

128

948

234

1.69

2.65

1.3

1.4

17.76

22.72

umol/l

0.67

220

Injuries to the wrist and hand

313

1797

1.21

2.62

1.4

1.6

22.81

24.86

umol/l

0.62

292

1718

Spinal osteochondrosis

4.72

2.60

2.0

1.0

24.46

18.13

umol/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

134

1.95

2.60

1.7

1.4

18.96

23.92

umol/l

0.55

128

Fracture of shoulder and upper arm

100

721

1.39

2.59

1.4

1.6

18.96

24.66

umol/l

1.45

685

Other or unspecified common variable immunodeficiency

5.67

2.57

5.2

1.3

8.93

12.17

umol/l

—

Metabolic disorder, other/unspecified

7.40

2.57

4.8

1.1

12.00

25.10

umol/l

—

Other and unspecified disorders of autonomic nervous system

5.63

2.57

1.5

1.2

50.00

12.64

umol/l

—

Disorders of vitreous body and globe

131

948

1.33

2.57

1.4

26.92

26.20

umol/l

0.09

121

895

Congenital lens malformations

5.60

2.56

1.2

1.1

13.92

20.15

umol/l

—

Scar conditions and fibrosis of skin

2.24

2.54

1.7

1.2

28.01

26.30

umol/l

0.08

Disorders of lipoprotein metabolism and other lipidaemias

208

1026

1.26

2.51

1.4

19.63

27.56

umol/l

4.00

197

972

Senile cataract

149

697

1.31

2.50

1.6

1.4

22.58

26.76

umol/l

0.91

144

652

Inflammatory diseases of prostate (prostatitis)

136

1.92

2.50

1.3

1.6

25.89

26.28

umol/l

0.02

130

Other secondary gonarthrosis

2.21

2.47

1.1

1.3

17.50

25.23

umol/l

0.61

Other symptoms and signs involving the urinary system

158

1.84

2.47

1.7

1.4

29.01

26.62

umol/l

0.14

150

Superficial injury of wrist and hand

496

1.45

2.44

1.5

1.6

16.33

24.65

umol/l

2.72

475

Effects of foreign body entering through natural orifice

505

1.45

2.42

1.3

1.6

24.56

23.86

umol/l

0.07

487

Salpingitis and oophoritis

383

1.52

2.42

1.7

1.4

16.54

28.38

umol/l

3.46

359

Alopecia universalis

6.51

2.40

1.2

2.1

45.56

22.16

umol/l

—

Disorders of aromatic amino-acid metabolism

6.47

2.39

6.2

1.0

14.92

22.66

umol/l

—

Disorder of carbohydrate metabolism, other/unspecified

6.46

2.39

6.2

1.9

13.60

11.59

umol/l

—

Thyrotoxicosis

565

1.42

2.38

1.4

1.5

34.50

24.81

umol/l

1.49

537

Other benign neoplasms of skin

717

1.37

2.37

1.3

1.5

24.18

25.31

umol/l

0.14

682

Transient ischemic attack

116

702

1.34

2.37

1.5

1.4

23.04

25.88

umol/l

0.45

108

665

Other protozoal intestinal diseases

3.67

2.37

1.4

1.2

20.75

22.79

umol/l

—

Macular pucker

220

1.69

2.37

1.3

1.4

30.43

24.08

umol/l

0.49

212

Fracture of femur

348

1.51

2.36

1.9

1.4

13.71

24.83

umol/l

3.91

333

Pure hypercholesterolaemia

180

929

1.27

2.35

1.4

21.22

27.58

umol/l

2.24

171

881

Paracetamol or NSAID medication

181

1.56

2.35

1.9

1.8

24.95

22.82

umol/l

0.19

176

Fracture of neck

2.26

2.34

1.6

1.2

21.56

23.27

umol/l

0.07

Traumatic subdural haemorrhage

120

1.92

2.33

2.0

1.3

14.98

25.35

umol/l

1.43

114

Other disorders of the genitourinary system

229

1.66

2.32

2.2

1.4

18.54

24.37

umol/l

0.70

217

Other and unspecified disorders of vitreous body

105

769

1.35

2.31

1.4

1.3

30.26

25.95

umol/l

0.63

725

Short stature starting before birth

3.62

2.30

2.0

2.5

23.39

12.89

umol/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.67

2.28

1.5

1.4

29.10

23.41

umol/l

—

Necrosis of pulp, including avohilmo

174

1383

1.26

2.27

1.7

1.5

21.22

26.12

umol/l

1.58

165

1322

Type 1 diabetes

536

1.42

2.27

1.6

1.7

24.52

25.00

umol/l

0.05

514

Other noninflammatory disorders of uterus, except cervix

270

1.50

2.25

1.5

1.4

26.09

27.29

umol/l

0.10

253

Ptosis of eyelid

171

1.76

2.24

1.3

1.4

19.65

25.12

umol/l

0.55

162

Persons with potential health hazards related to communicable diseases

135

1036

1.29

2.24

2.0

1.6

22.88

24.09

umol/l

0.19

129

998

Malignant neoplasm of skin

112

575

1.34

2.23

1.3

1.4

22.29

23.00

umol/l

0.09

104

541

Pustular psoriasis

2.10

2.23

1.1

1.4

15.50

24.93

umol/l

1.16

Abnormal blood-pressure reading, without diagnosis

2.20

2.21

2.3

1.3

36.92

22.46

umol/l

0.73

Infections with a predominantly sexual mode of transmission

103

769

1.34

2.20

1.3

1.5

26.09

25.10

umol/l

0.12

739

Other or unspecified immunodeficiency

4.43

2.17

1.7

1.6

42.38

18.21

umol/l

—

Other and unspecified disorders of binocular movement

4.38

2.16

1.0

2.1

25.08

23.20

umol/l

—

Other and unspecified bullous disorders

3.73

2.16

1.4

1.7

21.30

19.85

umol/l

—

Meniscus derangement

140

733

1.29

2.15

1.4

1.5

22.83

28.56

umol/l

1.46

133

699

Other protozoal intestinal diseases

2.80

2.14

1.3

19.11

26.19

umol/l

—

Ischaemic heart disease, wide definition

188

937

1.24

2.14

1.3

1.5

20.82

26.93

umol/l

2.18

171

891

Artificial joint operation, meniscal resection

233

1249

1.21

2.09

1.4

1.5

22.01

25.92

umol/l

1.23

220

1181

Lichen planopilaris

5.16

2.09

1.0

11.84

20.03

umol/l

—

Excessive earwax

138

1056

1.28

2.09

1.8

1.5

24.25

24.34

umol/l

0.01

128

1004

Congenital cataract

5.12

2.08

1.2

1.0

14.50

21.11

umol/l

—

Gonarthrosis,primary

224

1136

1.22

2.06

1.3

1.4

21.38

26.42

umol/l

1.82

212

1075

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

417

1.44

2.06

2.3

1.8

18.97

22.23

umol/l

0.51

402

Hereditary deficiency of other clotting factors

4.05

2.04

5.0

1.1

11.48

24.17

umol/l

—

Primary gonarthrosis, bilateral

117

770

1.30

2.04

1.4

16.64

27.37

umol/l

5.30

112

723

Intermittent heterotropia

154

1.76

2.03

2.3

1.8

14.83

23.95

umol/l

1.55

148

Other specified/unspecified soft tissue disorders

2.11

2.02

1.7

1.2

36.26

22.16

umol/l

0.76

Deep bite

292

1.51

2.02

2.2

1.8

22.50

22.82

umol/l

0.03

280

Other malignant neoplasms of skin (=non-melanoma skin cancer)

491

1.34

2.00

1.3

1.4

21.65

22.03

umol/l

0.04

459

Anosmia

3.90

1.98

1.0

36.87

39.69

umol/l

—

Bilateral cryptorchidism (undescended testicles)

4.77

1.97

2.4

3.3

14.72

11.72

umol/l

—

Selective deficiency of immunoglobulin A [IgA]y

4.65

1.95

1.8

1.7

12.80

12.34

umol/l

—

Injury of nerves at ankle and foot level

4.61

1.95

1.6

1.1

22.26

18.71

umol/l

—

Injury of muscle and tendon at shoulder and upper arm level

575

1.36

1.87

1.3

1.5

22.38

24.44

umol/l

0.26

551

Basal cell carcinoma

472

1.34

1.86

1.3

1.4

22.57

21.90

umol/l

0.08

444

Respiratory distress of newborn

1.97

1.86

2.9

2.7

12.33

15.07

umol/l

1.23

Pustulosis palmaris et plantaris

2.06

1.80

1.1

1.5

16.16

23.99

umol/l

0.73

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

674

1.32

1.80

1.6

20.83

25.32

umol/l

0.91

645

Other demyelinating diseases of the central nervous system

1.96

1.80

1.5

1.4

15.84

28.70

umol/l

1.69

Basal cell carcinoma, including avohilmo

504

1.31

1.77

1.3

1.4

22.09

22.12

umol/l

0.00

472

Congenital malformations of heart and great arteries

334

1.45

1.77

1.9

14.60

21.60

umol/l

3.09

321

Viral infections of the central nervous system

139

1.73

1.75

1.7

1.6

25.94

25.51

umol/l

0.02

131

Other and unspecified aplastic anaemias

3.37

1.75

1.7

1.6

13.55

21.63

umol/l

—

Birth trauma

2.97

1.73

1.1

2.6

26.36

13.09

umol/l

—

Pedal cyclist injured in collision with pedestrian or animal

3.90

1.72

1.0

1.2

28.88

12.30

umol/l

—

Delivery

645

0.77

1.72

1.3

1.6

20.75

24.13

umol/l

0.61

613

Other disorders originating in the perinatal period

2.33

1.72

3.6

2.3

13.96

13.08

umol/l

0.21

Viral hepatitis

140

1.72

1.71

2.5

1.6

17.90

27.32

umol/l

1.07

132

Female infertility, associated with anovulation

171

1.64

1.70

1.5

1.4

18.11

27.73

umol/l

1.30

166

Leiomyoma of uterus

198

933

1.20

1.70

1.3

1.4

28.14

26.47

umol/l

0.29

186

882

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

444

1.38

1.68

2.3

1.8

18.88

21.95

umol/l

0.49

428

Chronic suppurative otitis media

126

1.75

1.67

1.5

1.4

15.85

24.47

umol/l

0.95

119

Bacterial sepsis of newborn

2.64

1.67

1.6

2.4

12.10

12.09

umol/l

—

Moderate mental retardation

3.21

1.67

2.3

1.7

13.60

12.62

umol/l

—

Migraine with aura, drug-induced

3.19

1.66

2.0

1.2

35.85

20.02

umol/l

—

Cardiac arrest

1.96

1.66

2.5

1.3

15.80

28.41

umol/l

1.40

Other benign neoplasms of connective and other soft tissue

188

1.60

1.65

1.3

1.5

27.31

24.67

umol/l

0.16

178

Single spontaneous delivery

643

0.77

1.65

1.4

1.6

20.33

24.17

umol/l

0.75

611

Endometriosis ASRM stages 3,4

555

1.34

1.63

1.5

1.4

23.97

26.53

umol/l

0.32

525

Persons encountering health services in circumstances related to reproduction

188

1055

1.20

1.63

1.7

1.6

26.31

24.64

umol/l

0.30

175

1014

COPD-related respiratory insufficiency

150

1.67

1.63

1.2

1.4

13.06

25.04

umol/l

2.66

144

Other disorders affecting eyelid function

3.61

1.62

1.0

1.3

11.08

17.51

umol/l

—

Other specified and unspecified disorders of conjunctiva

3.60

1.62

1.6

1.2

27.00

29.21

umol/l

—

Sub-endpoint used in defining T1D endpoints

598

1.32

1.61

1.6

1.7

23.73

22.83

umol/l

0.09

574

Specific development disorders of scholastic skills

126

1.73

1.61

2.4

1.8

30.79

23.10

umol/l

0.50

121

Viral infections of the central nervous system

151

1.66

1.59

1.7

1.6

25.18

24.86

umol/l

0.02

143

Periapical abscess

123

991

1.24

1.57

1.6

1.5

18.13

25.45

umol/l

2.87

116

944

Open wound of abdomen, lower back and pelvis

2.12

1.55

3.2

1.2

19.42

29.47

umol/l

0.76

Tubulo-interstitial nephritis, not specified as acute or chronic

107

1.78

1.54

2.4

1.3

22.45

26.89

umol/l

0.30

101

Fetus and newborn affected by maternal complications of pregnancy

0.00

1.54

0.0

2.3

—

13.76

—

Localized adiposity

3.39

1.53

1.6

1.3

11.76

26.98

umol/l

—

Onycholysis

3.38

1.53

3.2

1.1

12.38

17.33

umol/l

—

Injury of nerves at shoulder and upper arm level

3.36

1.52

1.8

1.3

10.46

21.65

umol/l

—

Other congenital malformations, not elsewhere classified

2.89

1.51

1.5

1.4

13.73

22.66

umol/l

—

Nonpyogenic thrombosis of intracranial venous system

2.89

1.51

1.8

1.4

10.33

23.36

umol/l

—

Raynaud syndrome

193

1.56

1.51

1.5

23.22

24.43

umol/l

0.08

182

Impacted maxillary molar

154

1.63

1.50

1.5

23.50

25.90

umol/l

0.16

145

Retinal detachments and breaks

581

1.31

1.49

1.5

1.4

21.30

26.06

umol/l

0.73

555

Striking against or struck by other objects

757

1.27

1.48

1.7

1.6

22.38

23.65

umol/l

0.16

729

Benign neoplasm: Rectum, anus and anal canal

300

1.44

1.48

1.4

27.63

25.16

umol/l

0.19

286

Stroke, including SAH

137

814

1.22

1.46

1.3

1.4

17.48

25.12

umol/l

3.39

132

770

Malignant neoplasm of ovary

1.85

1.46

1.6

1.4

52.46

22.53

umol/l

2.10

Other diseases of oesophagus

132

1.67

1.45

2.4

1.3

20.98

25.69

umol/l

0.37

124

Other and unspecified vaccines and biological substances

3.17

1.44

1.2

2.3

45.78

21.88

umol/l

—

Atypical mycobacterium lung infection

3.15

1.44

1.8

1.4

12.04

21.01

umol/l

—

Graves ophthalmopathy, strict

2.32

1.43

1.1

1.3

49.73

28.58

umol/l

—

Malignant neoplasm of ovary, including Hilmo

118

1.70

1.41

1.7

1.3

48.32

22.11

umol/l

2.07

111

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.86

1.40

1.7

1.4

14.61

25.93

umol/l

1.56

Intrahepatic Cholestasis of Pregnancy (ICP)

199

0.50

1.40

1.8

1.5

20.20

23.22

umol/l

—

190

Benign neoplasm: Rectum

271

1.44

1.39

1.4

25.32

24.20

umol/l

0.08

258

Other chromosome abnormalities, not elsewhere classified

2.67

1.38

2.3

3.0

12.10

11.35

umol/l

—

Injury of other and unspecified intrathoracic organs

1.80

1.37

1.4

23.54

26.59

umol/l

0.13

Stroke, excluding SAH

125

747

1.22

1.37

1.4

17.45

25.23

umol/l

3.16

120

708

Appendectomy

190

1551

1.17

1.36

1.6

1.5

25.56

25.38

umol/l

0.03

185

1469

Drug-induced hypoglycaemia without coma

2.96

1.36

1.4

8.00

21.24

umol/l

—

Tooth eruption problems

406

1.35

1.4

1.8

20.22

21.48

umol/l

0.15

389

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

135

1.63

1.35

2.3

1.4

22.18

24.17

umol/l

0.13

127

Delivery, wide proxy

535

0.78

1.32

1.3

1.6

23.02

23.36

umol/l

0.03

510

Diabetic retinopathy, excluding more controls

290

1.32

1.30

1.6

18.93

22.11

umol/l

0.41

270

Other predominantly sexually transmitted diseases, not elsewhere classified

524

1.30

1.4

1.6

25.24

25.39

umol/l

0.01

497

Other forms of systemic lupus erythematosus

2.81

1.29

1.0

1.1

10.78

22.06

umol/l

—

Follicular cysts of skin and subcutaneous tissue

327

1.38

1.27

1.5

24.43

25.61

umol/l

0.09

310

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

178

1205

1.17

1.25

1.5

1.4

26.10

25.92

umol/l

0.03

166

1152

Other enthesopathies

581

1.27

1.24

1.5

24.41

26.77

umol/l

0.26

552

Type 1 diabetes, wide definition, subgroup 1

441

1.32

1.23

1.8

1.6

21.15

24.74

umol/l

0.42

423

Schizoaffective disorder

163

1.54

1.23

1.2

1.5

20.95

25.05

umol/l

0.33

153

Social disorders starting during childhood or adolescence

2.66

1.22

3.6

3.3

11.28

12.68

umol/l

—

Contraceptive management

128

747

1.20

1.21

1.5

27.13

26.77

umol/l

0.04

116

717

Vulvovaginal ulceration/inflammation in other diseases

156

1.54

1.20

2.0

1.6

14.70

24.13

umol/l

1.87

148

Sequelae of other external causes

101

1.69

1.19

1.8

1.3

16.81

25.61

umol/l

0.73

Other complications of labour and delivery, not elsewhere classified

319

0.66

1.18

1.3

1.6

24.75

24.29

umol/l

0.03

309

Coxarthrosis [arthrosis of hip](FG)

113

656

1.21

1.18

1.2

1.4

18.65

28.79

umol/l

3.78

107

623

Drug-induced neutropenia

125

1.60

1.17

1.3

1.4

22.05

24.68

umol/l

0.16

118

Social disorders starting during childhood or adolecense, excluding more controls

2.52

1.15

3.6

3.2

11.28

24.38

umol/l

—

Scarlet fever

2.52

1.15

1.2

1.5

11.36

21.43

umol/l

—

Phakomatoses, not elsewhere classified

2.52

1.15

1.6

1.2

26.50

16.72

umol/l

—

Coxarthrosis

105

570

1.22

1.14

1.3

1.5

19.19

28.95

umol/l

3.17

100

547

Cysts of oral region, not elsewhere classified

1.69

1.13

1.3

1.2

16.47

26.68

umol/l

1.12

Type 1 diabetes, wide definition

474

1.29

1.12

1.7

20.90

24.25

umol/l

0.41

454

Benign lipomatous neoplasm

564

1.26

1.11

1.3

1.5

21.23

25.89

umol/l

0.70

537

LSIL lesion of the vagina

2.27

1.10

1.3

1.2

12.57

25.84

umol/l

—

Diabetic retinopathy

416

1.24

1.10

1.5

18.35

21.35

umol/l

0.47

391

Acute lymphocytic leukaemia, including Hilmo

2.41

1.09

3.6

2.6

10.46

12.99

umol/l

—

Acute lymphocytic leukaemia, helper endpoint

2.41

1.09

3.6

2.6

10.46

12.99

umol/l

—

Acute lymphocytic leukaemia

2.41

1.09

3.6

2.6

10.46

12.99

umol/l

—

Radial styloid tenosynovitis [de Quervain]

120

1.59

1.08

1.3

1.4

24.90

28.00

umol/l

0.16

113

Abnormal findings in secretions and smears from cervix uteri vagina vulva

163

1061

1.16

1.08

1.4

26.51

26.09

umol/l

0.06

152

1014

Disorders of orbit

1.69

1.07

1.3

1.4

39.23

27.35

umol/l

0.51

Motorcycle rider injured in other and unspecified transport accidents

105

1.62

1.06

1.2

1.7

27.68

24.99

umol/l

0.11

100

Foreign body entering into or through eye or natural orifice

145

1.52

1.05

1.1

1.5

18.19

24.59

umol/l

0.67

138

Other viral hepatitis

121

1.57

1.05

2.5

1.6

15.61

29.27

umol/l

1.89

113

Undescended testicle

2.02

1.05

3.1

2.9

14.29

13.59

umol/l

—

Sequelae of infectious and parasitic diseases

129

1.55

1.05

1.4

23.57

26.41

umol/l

0.16

123

Myocardial infarction

531

1.22

1.04

1.3

1.5

14.17

25.44

umol/l

5.96

507

Cardiovascular disorders originating in the perinatal period

2.31

1.04

2.8

2.3

11.56

12.20

umol/l

—

Left bundle-branch block

1.67

1.04

1.4

1.3

22.42

29.79

umol/l

0.50

Glaucoma suspect

635

1.23

1.01

1.4

21.37

25.51

umol/l

0.65

597

Gonarthrosis, primary, with knee surgery

119

803

1.18

0.99

1.3

1.4

19.07

27.18

umol/l

2.58

113

755

Eustachian salpingitis and obstruction

173

1.45

0.97

1.6

28.35

24.37

umol/l

0.23

165

Outcome of delivery

334

0.76

0.96

1.4

1.5

27.96

26.00

umol/l

0.15

322

Myocardial infarction, without ST-elevation

476

1.24

0.95

1.3

1.4

15.79

24.66

umol/l

2.43

452

Unspecified lump in breast

337

1.31

0.95

1.3

1.5

31.19

25.89

umol/l

0.49

321

Pregnancy, childbirth and the puerperium

451

0.81

0.95

1.1

1.6

23.26

24.54

umol/l

0.13

430

Mixed connective tissue disease

133

1.51

0.94

1.3

1.5

19.55

24.60

umol/l

0.36

125

Disorders of continuity of bone

209

1.39

0.92

1.6

1.4

22.31

25.59

umol/l

0.24

198

Sequelae of other and unspecified infectious and parasitic diseases

110

1.55

0.90

1.4

1.5

25.87

27.60

umol/l

0.08

105

Chronic suppurative otitis media, including avohilmo

168

1.43

0.89

1.5

1.7

18.28

22.84

umol/l

0.40

161

Open wound of wrist and hand

114

954

1.17

0.89

1.4

1.6

26.49

24.83

umol/l

0.22

107

914

Varicose veins of other sites

105

0.48

0.88

1.6

1.5

58.64

25.32

umol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

112

955

1.17

0.87

1.4

1.6

25.22

24.54

umol/l

0.08

107

916

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

168

0.59

0.86

1.8

1.4

20.20

25.42

umol/l

—

159

Vasomotor rhinitis (mode)

136

1.47

0.86

1.5

1.4

16.39

26.12

umol/l

1.09

128

Propionic acid derivatives

319

1.21

0.84

1.3

1.8

30.78

21.77

umol/l

1.40

305

Cramp and spasm

1.60

0.84

1.5

1.3

12.66

26.66

umol/l

3.78

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

227

1.35

0.83

1.7

2.0

17.19

21.68

umol/l

0.65

219

Unspecified dementia

104

0.52

0.83

1.3

8.80

21.52

umol/l

—

Ménière disease

155

1.42

0.81

1.3

1.4

17.49

22.59

umol/l

0.44

146

Hodgkin lymphoma, hilmo

1.71

0.80

1.1

1.2

10.38

23.62

umol/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.79

0.0

1.2

—

25.82

—

Chronic viral hepatitis

1.53

0.78

2.2

1.6

10.51

30.61

umol/l

6.64

Hyperlipidaemia, other/unspecified

519

1.21

0.78

1.2

1.3

21.51

26.07

umol/l

0.64

491

Contact with machinery

148

1.42

0.77

1.5

1.4

18.81

24.42

umol/l

0.51

141

Hallux valgus (acquired)

484

1.19

0.77

1.3

1.4

25.54

30.86

umol/l

0.71

462

Postpartum haemorrhage due to anatomy

243

1.32

0.77

1.2

1.4

22.23

25.42

umol/l

0.28

233

Statin medication

208

1054

1.11

0.74

1.4

1.6

21.17

28.04

umol/l

2.92

200

1006

HSIL lesion of the cervix uteri, vagina or vulva

523

1.21

0.74

1.4

1.5

25.51

26.27

umol/l

0.07

502

Later onset COPD, excluding more controls

168

1.33

0.73

1.2

1.4

13.03

23.22

umol/l

2.31

158

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.01

0.73

1.0

1.6

12.80

12.62

umol/l

—

Glaucoma

115

864

1.15

0.72

1.4

23.36

25.24

umol/l

0.28

109

811

Acute lymphadenitis

125

1.44

0.72

1.2

1.6

11.40

25.80

umol/l

6.01

119

Undefined dementia

101

0.55

0.72

1.3

8.80

21.36

umol/l

—

Pedal cyclist injured in other and unspecified transport accidents

230

0.69

0.72

1.6

28.15

24.63

umol/l

0.20

218

Residual foreign body in soft tissue

1.55

0.72

1.0

1.4

25.16

25.08

umol/l

0.00

Tic and related disorders

1.93

0.71

1.2

2.4

37.54

15.69

umol/l

—

Convergent concomitant strabismus

135

1.41

0.69

2.1

1.6

16.19

25.02

umol/l

1.05

128

Parkinson's disease, including avohilmo

196

1.33

0.67

1.1

1.4

26.32

23.20

umol/l

0.20

186

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.80

0.66

2.4

2.2

11.48

12.08

umol/l

—

CR(E)ST syndrome

1.79

0.66

1.6

1.2

10.32

24.98

umol/l

—

Slow fetal growth and fetal malnutrition

1.79

0.66

2.0

2.8

11.86

12.28

umol/l

—

Medical abortion

197

969

1.10

0.65

1.3

1.5

22.15

27.65

umol/l

1.90

182

918

Septal defects

202

1.31

0.64

2.1

2.0

15.95

20.01

umol/l

0.64

194

Polyhydramnios

128

0.62

0.64

1.6

30.20

21.99

umol/l

—

122

Scabies

1.50

0.63

1.8

1.6

16.94

26.95

umol/l

0.82

Other specific arthropathies, wide

1.67

0.61

1.2

1.3

39.02

28.96

umol/l

—

Abnormal findings on antenatal screening of mother

222

0.72

0.61

1.3

1.6

25.73

26.23

umol/l

0.02

208

Major coronary heart disease event excluding revascularizations

115

678

1.13

0.61

1.3

1.5

16.80

25.23

umol/l

3.37

107

644

Conductive hearing loss, unspecified

156

1.35

0.61

2.2

1.6

28.10

25.06

umol/l

0.16

146

Malignant neoplasm of breast, HER2-negative

667

0.87

0.61

1.3

1.4

37.75

24.49

umol/l

2.68

630

Other congenital malformations of skull and face bones

0.00

0.60

0.0

2.7

—

11.56

—

Contact with venomous snakes and lizards

0.00

0.60

0.0

1.3

—

19.14

—

Carcinoma in situ of breast, other/unspecified

0.00

0.59

0.0

1.1

—

20.22

—

Other peripheral vascular diseases

157

1.34

0.59

1.5

1.4

27.90

24.83

umol/l

0.15

148

Pregnancy with abortive outcome

205

979

1.09

0.58

1.3

1.5

22.11

27.47

umol/l

1.86

193

928

Pediculosis, acariasis and other infestations

106

1.42

0.57

1.7

1.5

23.21

26.38

umol/l

0.14

100

Haemorrhage in early pregnancy

734

1.14

0.56

1.3

1.5

22.30

27.08

umol/l

0.89

700

Melanocytic naevi of other and unspecified parts of face

115

1.39

0.56

1.9

1.4

18.04

24.56

umol/l

0.45

109

Benign neoplasm of bone and articular cartilage

168

1.31

0.55

1.5

1.6

28.77

25.88

umol/l

0.16

160

L02BA Anti-estrogens

373

0.80

0.54

1.5

41.19

25.86

umol/l

1.41

354

Postpartum hemorraghe, parous women as controls

557

1.15

0.53

1.3

1.4

26.34

26.52

umol/l

0.02

536

Any death

130

840

1.11

0.53

1.5

1.4

34.01

24.73

umol/l

2.01

122

795

Labour and delivery complicated by fetal stress [distress]

505

0.87

0.52

1.4

1.6

23.00

25.54

umol/l

0.31

489

Other necrotizing vasculopathies

100

1.40

0.51

1.7

1.4

11.06

21.89

umol/l

3.58

Anti-inflammatory and antirheumatic products, non-steroids

319

1.15

0.51

1.3

1.8

28.08

21.77

umol/l

0.84

305

Other and unspecified disorders of psychological development

1.48

0.50

1.5

3.1

12.33

13.08

umol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

809

1.12

0.48

1.4

1.5

24.32

26.04

umol/l

0.23

778

Abnormal findings on diagnostic imaging of central nervous system

1.40

0.48

4.1

1.5

30.18

27.75

umol/l

0.09

Spontaneous abortion

139

854

1.10

0.48

1.3

1.5

20.63

28.43

umol/l

2.85

131

808

Other maternal disorders predominantly related to pregnancy

182

1053

1.08

0.47

1.4

1.5

24.70

26.95

umol/l

0.46

170

999

Preterm labour and delivery

664

1.13

0.46

1.3

1.5

26.99

26.53

umol/l

0.04

637

Complications of the puerperium, not elsewhere classified

120

0.67

0.45

1.3

1.5

23.25

25.08

umol/l

—

115

Etanercept

156

1.28

0.45

1.3

1.5

22.14

24.61

umol/l

0.16

147

Malignant neoplasm of breast

675

0.90

0.44

1.3

1.4

36.85

24.60

umol/l

2.46

637

Vitreous haemorrhage

166

1.27

0.43

1.3

1.4

19.05

24.00

umol/l

0.39

159

Thoracic aortic aneurysm

166

1.27

0.43

2.0

1.3

21.04

24.30

umol/l

0.22

160

Undescended testis, unilateral

1.57

0.42

4.8

2.9

13.40

12.72

umol/l

—

Cyst of Bartholin Gland

0.64

0.42

1.2

1.4

52.74

25.39

umol/l

—

Benign neoplasm: Long bones of lower limb

1.41

0.42

1.8

1.4

21.66

30.09

umol/l

—

Other and unspecified glaucoma

0.63

0.42

1.0

1.3

25.60

20.16

umol/l

—

Congenital malformations of larynx

0.00

0.41

0.0

1.9

—

11.63

—

Accessory breast

0.00

0.41

0.0

1.1

—

22.64

—

Blindness, monocular

0.00

0.41

0.0

1.1

—

17.55

—

Atypical virus infections of central nervous system

0.00

0.41

0.0

1.4

—

22.26

—

Nontoxic goitre/thyroid nodule

595

1.13

0.41

1.2

1.4

31.09

25.81

umol/l

0.58

559

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.1

—

17.49

—

Lower leg

0.00

0.41

0.0

1.2

—

16.36

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.48

0.40

2.4

2.1

11.48

14.21

umol/l

—

Benign leiomyoma with endometriosis

324

1.17

0.40

1.3

1.4

38.01

25.62

umol/l

1.16

308

Cellulitis of external ear

0.00

0.40

0.0

1.3

—

24.93

—

Palatinal maxillary canine

0.00

0.39

0.0

2.4

—

17.18

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.39

0.0

1.1

—

26.10

—

Angina pectoris

103

626

1.10

0.38

1.3

1.5

22.05

26.16

umol/l

0.70

592

Benign neoplasm of brain and other parts of central nervous system

112

0.71

0.37

1.5

1.4

11.56

25.49

umol/l

—

104

Other appendicitis

161

1.24

0.37

1.1

1.4

38.49

25.59

umol/l

0.85

152

Diabetes mellitus in pregnancy

114

671

1.09

0.36

1.5

20.91

26.24

umol/l

1.35

108

643

Congenital malformations of eye, ear, face and neck

171

1.23

0.35

1.5

1.7

24.73

23.78

umol/l

0.05

161

Abnormal spermatozoa

124

0.73

0.35

1.1

1.5

19.60

26.31

umol/l

—

119

Other diseases of peritoneum

1.37

0.34

1.7

1.3

12.07

27.55

umol/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.69

0.33

4.3

2.8

14.82

14.81

umol/l

—

Benign neoplasm: Descending colon

1.31

0.31

1.3

26.05

23.81

umol/l

0.08

Maternal care for known or suspected fetal abnormality and damage

409

0.88

0.31

1.4

1.5

27.56

26.18

umol/l

0.11

391

Acute nasopharyngitis (common cold)

206

0.82

0.30

2.4

1.7

21.71

26.90

umol/l

0.34

197

Complications predominantly related to the puerperium

694

0.91

0.30

1.4

1.5

24.36

26.89

umol/l

0.27

666

Persistent delusional disorders

120

1.25

0.30

1.2

1.4

24.19

23.56

umol/l

0.02

112

Aneurysms, operations, SAH

287

1.15

0.30

1.3

1.4

21.95

24.26

umol/l

0.18

272

Foreign body or object entering through skin

112

1.25

0.28

1.1

1.5

16.15

27.75

umol/l

1.05

106

Cluster headache, strict, including avohilmo

103

1.26

0.28

1.5

1.4

12.08

27.05

umol/l

5.01

Pedestrian injured in transport accident

119

0.76

0.27

1.1

1.3

21.62

25.60

umol/l

—

112

Myocarditis

1.21

0.26

2.1

1.2

20.66

26.96

umol/l

—

Malignant neoplasm of breast, including Hilmo

687

0.93

0.26

1.5

1.4

35.18

24.76

umol/l

2.06

649

Malignant neoplasm of breast, HER2-negative, including Hilmo

687

0.93

0.26

1.5

1.4

35.18

24.76

umol/l

2.06

649

Coxarthrosis, primary

109

864

1.07

0.26

1.2

1.4

17.71

25.81

umol/l

2.87

103

811

Congenital ovarian cysts

123

1.22

0.25

1.7

1.4

28.17

26.05

umol/l

0.09

115

Toxic effect of ethanol

1.20

0.25

3.3

1.5

10.89

25.12

umol/l

—

L01XX Other antineoplastic agents

1.18

0.24

1.4

1.3

35.81

19.31

umol/l

—

Superficial injury of shoulder and upper arm

217

1.15

0.24

1.6

1.5

16.82

24.24

umol/l

1.07

207

Burn and corrosion of wrist and hand

1.17

0.24

2.1

1.6

11.79

28.02

umol/l

—

Inflammatory disorders of breast

161

1.18

0.24

1.2

1.5

28.13

25.36

umol/l

0.14

153

Maternal care for other known or suspected fetal problems

495

1.07

0.23

1.4

1.6

24.98

25.45

umol/l

0.05

475

Sarcoidosis

246

1.14

0.23

1.7

1.3

40.89

24.44

umol/l

1.39

234

Maternal care for other conditions predominantly related to pregnancy

589

1.08

0.23

1.6

1.5

17.92

26.72

umol/l

2.72

564

Melanocytic naevi of lower limb, including hip

1.25

0.22

1.3

33.84

24.29

umol/l

0.37

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.22

0.0

2.7

—

11.27

—

Changes in corneal membranes

0.00

0.21

0.0

1.0

—

19.90

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.0

—

19.98

—

Pituitary-dependent Cushing's disease

0.00

0.21

0.0

1.2

—

19.48

—

Cleft lip

0.00

0.21

0.0

1.1

—

12.37

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.21

0.0

1.1

—

38.72

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.0

—

20.07

—

Lesion of medial popliteal nerve

0.00

0.21

0.0

1.1

—

20.14

—

Findings of drugs and other substances, not normally found in blood

0.00

0.21

0.0

1.3

—

25.41

—

Moderate visual impairment, monocular

0.00

0.21

0.0

1.1

—

19.12

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.1

—

20.42

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

19.01

—

Colour vision deficiencies

0.00

0.21

0.0

1.9

—

11.65

—

Tick-borne viral encephalitis

0.00

0.21

0.0

1.2

—

13.00

—

Necrotizing fasciitis

0.00

0.21

0.0

1.0

—

11.22

—

Familial erythrocytosis

0.00

0.21

0.0

1.0

—

20.83

—

Right side

0.00

0.21

0.0

1.4

—

26.38

—

Discontinuity and dislocation of ear ossicles

0.00

0.21

0.0

1.6

—

26.78

—

Thiamine deficiency

0.00

0.21

0.0

1.2

—

20.74

—

Contact with hot air and gases

0.00

0.21

0.0

1.6

—

19.52

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.5

—

23.88

—

Degenerative myopia

0.00

0.21

0.0

1.4

—

25.65

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.3

—

24.32

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

18.61

—

Cholinergic urticaria

0.00

0.21

0.0

1.3

—

24.43

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

0.21

0.0

1.2

—

24.60

—

Felty syndrome

0.00

0.21

0.0

1.1

—

18.85

—

Serous carcinoma of ovary

0.00

0.21

0.0

1.6

—

19.61

—

Other mosquito-borne viral fevers

0.00

0.21

0.0

1.4

—

24.92

—

Use of entacapone

0.00

0.21

0.0

1.3

—

24.52

—

Hyperprolactinaemia, drug-induced

0.00

0.21

0.0

1.1

—

24.92

—

Maxillary prognathism

0.00

0.21

0.0

2.3

—

12.42

—

Carcinoma in situ of breast

0.00

0.21

0.0

1.1

—

18.18

—

Toxic effect of other gases, fumes and vapours

0.00

0.21

0.0

1.2

—

12.12

—

Meningococcal infection

0.00

0.21

0.0

1.3

—

24.04

—

Personal history of malignant neoplasm

134

0.82

0.20

1.4

1.5

24.59

21.86

umol/l

0.10

128

Carcinoma in situ of uteri, other/unspecified

0.00

0.20

0.0

1.1

—

17.66

—

Cystic disease of liver

0.00

0.20

0.0

1.1

—

17.66

—

Osteochondrosis of ankle, juvenile

0.00

0.20

0.0

1.3

—

18.14

—

Lesion of femoral nerve

0.00

0.20

0.0

1.1

—

17.43

—

Tobacco use

1.22

0.19

1.1

1.3

12.08

30.58

umol/l

5.28

Abnormalities of forces of labour

291

0.89

0.19

1.4

1.6

22.89

25.62

umol/l

0.22

283

Later onset COPD

255

0.91

0.17

1.2

1.3

13.03

22.36

umol/l

2.28

237

Male infertility

1.18

0.16

2.1

1.5

22.21

33.33

umol/l

—

Injury of unspecified body region

141

0.85

0.16

2.9

1.6

30.46

24.36

umol/l

0.23

133

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.13

0.15

1.3

36.73

24.03

umol/l

—

Other orthopaedic follow-up care

1.10

0.15

1.4

1.3

11.91

26.58

umol/l

—

Cluster headache, wide,, including avohilmo

112

1.16

0.14

1.5

1.4

12.08

26.70

umol/l

5.28

106

Other diseases of blood and blood-forming organs

112

1.16

0.14

2.5

1.3

12.80

26.61

umol/l

4.28

105

Malignant neoplasm of corpus uteri, including Hilmo

151

1.13

0.13

1.6

1.3

29.62

22.56

umol/l

0.37

141

Parkinson's disease

190

1.11

0.12

1.1

1.4

29.53

22.78

umol/l

0.40

180

Otosclerosis

134

1.12

0.11

1.0

1.4

21.07

22.80

umol/l

0.08

126

Maternal care related to the fetus and amniotic cavity and possible delivery problems

142

810

1.03

0.10

1.3

1.5

30.77

25.57

umol/l

1.07

132

776

Other congenital malformations of skin

1.15

0.10

1.0

1.6

29.58

25.07

umol/l

0.17

Subarachnoid haemorrhage

164

1.10

0.09

1.1

1.5

20.26

21.34

umol/l

0.06

156

Complications of labour and delivery

180

1024

0.98

0.09

1.3

1.5

29.03

25.88

umol/l

0.64

161

977

Other osteochondropathies

136

1.10

0.08

1.7

1.4

15.99

26.36

umol/l

1.08

128

Conotruncal defects

1.03

0.08

1.0

2.4

12.88

14.46

umol/l

—

Obstructed labour due to malposition and malpresentation of fetus

619

0.96

0.08

1.4

1.5

29.35

26.31

umol/l

0.31

599

Chalazion

224

1.07

0.08

1.2

1.4

21.85

25.38

umol/l

0.24

212

Myocardial infarction, strict

481

1.04

0.08

1.3

1.5

14.30

24.90

umol/l

4.12

457

Diseases of appendix

187

1654

1.02

0.08

1.5

24.60

25.52

umol/l

0.16

180

1571

Cerebral aneurysm, nonruptured

164

0.91

0.08

1.6

1.4

24.07

24.78

umol/l

0.03

154

Appendicitis, broad definition

186

1651

1.02

0.08

1.5

24.60

25.55

umol/l

0.17

179

1568

Abscess of Bartholin gland

1.03

0.08

1.4

11.77

25.07

umol/l

—

Parkinson's disease, strict definition

176

1.08

0.07

1.1

1.4

31.29

22.12

umol/l

0.54

167

Other noninflammatory disorders of cervix uteri

1.05

0.07

1.3

1.4

20.24

26.44

umol/l

—

Lesion of plantar nerve

111

0.90

0.06

1.8

1.4

25.68

24.16

umol/l

—

104

Gestational diabetes (for exclusion)

119

811

1.02

0.06

1.6

1.5

21.11

26.25

umol/l

1.33

114

776

Inguinal hernia

110

749

0.98

0.05

1.5

21.83

23.97

umol/l

0.34

101

712

Myeloproliferative diseases (CML excluded)

110

0.91

0.05

1.2

1.3

13.04

23.42

umol/l

—

104

Other congenital malformations of skin

191

0.94

0.04

1.3

1.6

30.44

22.98

umol/l

0.45

182

Coxarthrosis, primary, with hip surgery

715

1.02

0.04

1.3

1.4

16.74

25.58

umol/l

2.77

674

Tooth agenesis EXCLUDE clefts and syndromes

109

0.92

0.04

2.4

1.9

12.00

21.87

umol/l

—

103

Postpartum hemorraghe, all women as controls

725

1.02

0.03

1.3

1.5

26.34

26.48

umol/l

0.01

697

Postpartum haemorrhage

641

0.98

0.02

1.3

1.6

26.34

26.08

umol/l

0.03

620

Retained placenta and membranes, without haemorrhage

299

0.97

0.02

1.3

1.5

29.62

24.67

umol/l

0.34

289

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

130

1119

1.01

0.02

1.5

1.4

25.18

26.67

umol/l

0.22

124

1061

False labour

612

0.99

0.02

1.3

1.6

29.74

24.96

umol/l

0.73

588

Nontoxic multinodular goitre

332

1.02

0.01

1.1

1.5

29.79

24.45

umol/l

0.36

311

Lyme disease

638

0.99

0.01

1.3

1.5

35.26

25.57

umol/l

1.17

608

Contact with and exposure to communicable diseases

879

1.01

0.01

2.0

1.6

24.44

24.27

umol/l

0.02

846

Contusion of other and unspecified parts of foot

116

0.95

0.00

2.5

1.6

18.72

24.68

umol/l

0.36

111

Normotensive glaucoma

124

1.05

0.00

1.2

1.4

30.05

19.78

umol/l

0.48

116

Myeloproliferative diseases

126

0.95

0.00

1.2

1.3

20.01

24.82

umol/l

0.26

120

Myocardial infarction, with ST-elevation

204

1.03

0.00

1.4

10.83

23.84

umol/l

7.76

197

Use of levodopa decarboxylase inhibitor

168

1.01

0.00

1.1

1.3

29.28

22.58

umol/l

0.35

160

Endovascular or surgical operations to intracerebral aneurysms

105

0.95

0.00

1.1

1.4

18.48

24.67

umol/l

—

100

Benign neoplasm: Adrenal gland

125

1.04

0.00

1.2

1.5

17.17

23.63

umol/l

0.56

118

Malignant neoplasm of corpus uteri

135

0.96

0.00

1.8

1.3

29.82

23.21

umol/l

0.28

125

Embedded teeth, including avohilmo

243

0.99

0.00

1.1

1.6

21.07

24.71

umol/l

0.32

230

Spirochaetal infections, other/unspecified

644

0.99

0.00

1.3

1.5

34.87

25.57

umol/l

1.12

613

Other spirochaetal diseases

646

1.01

0.00

1.4

1.5

34.54

25.50

umol/l

1.10

616

Divergent concomitant strabismus

158

1.01

0.00

1.4

1.5

16.44

24.72

umol/l

0.86

150

Acute appendicitis

171

1601

1.00

0.00

1.6

1.5

23.45

25.58

umol/l

0.44

164

1522

Other spirochaetal diseases

653

1.00

0.00

1.4

1.5

34.54

25.69

umol/l

1.07

622

Placenta praevia

127

1.02

0.00

1.9

1.6

44.80

22.65

umol/l

1.23

122

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

227

1.01

0.00

1.8

1.5

20.81

24.80

umol/l

0.33

215

Eclampsia

0.00

0.0

1.2

—

27.50

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.1

—

20.34

—

Congenital malformations of lung

0.00

0.0

2.8

—

21.31

—

Esophageal diverticulum (pouch)

0.00

0.0

1.0

—

10.34

—

Need for immunization against certain single viral diseases

0.00

0.0

1.2

—

12.90

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.0

—

12.33

—

Acute thyroiditis

0.00

0.0

1.1

—

12.90

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.1

—

21.18

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.7

—

23.35

—

Rifle, shotgun and larger firearm discharge

0.00

0.0

1.0

—

13.20

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.0

1.0

—

25.45

—

Tympanosclerosis

0.00

0.0

1.0

—

25.68

—

Indeterminate sex and pseudohermaphroditism

0.00

0.0

1.0

—

12.06

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.0

1.0

—

13.01

—

Burn and corrosion of other internal organs

0.00

0.0

1.4

—

12.38

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.0

—

13.30

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.4

—

20.69

—

Disease of thymus, other/unspecified

0.00

0.0

1.2

—

13.58

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.0

—

10.63

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.2

—

11.48

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.0

1.1

—

13.28

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.0

1.2

—

14.08

—

Other and unspecified heterotropia

0.00

0.0

1.1

—

22.14

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.3

—

22.66

—

Oher contracture of tendon (sheath)

0.00

-0.00

0.0

1.0

—

29.48

—

Other specific arthropathies

0.00

-0.00

0.0

1.1

—

12.11

—

Progressive osseous muscle inflammation

0.00

-0.00

0.0

1.0

—

12.58

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.3

—

12.41

—

Fatigue fracture of vertebra

0.00

-0.00

0.0

1.0

—

11.86

—

Other infective (teno)synovitis

0.00

-0.00

0.0

1.0

—

21.94

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.6

—

28.88

—

Ankylosis of joint

0.00

-0.00

0.0

1.0

—

12.25

—

Congenital retinoschisis

0.00

-0.00

0.0

1.6

—

32.24

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

12.90

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.0

—

28.46

—

Ebstein's anomaly

0.00

-0.00

0.0

1.9

—

11.93

—

Other and unspecified localized connective tissue disorders

0.00

-0.00

0.0

1.0

—

21.09

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.1

—

12.13

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.3

—

12.48

—

Café au lait spots

0.00

-0.00

0.0

2.3

—

11.12

—

Oesophagitis, drug-induced

0.00

-0.00

0.0

1.0

—

12.22

—

Calcinosis cutis

0.00

-0.00

0.0

1.0

—

13.17

—

Liver disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

24.37

—

Qualitative platelet defects

0.00

-0.00

0.0

1.0

—

11.78

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

41.32

—

Complications of anaesthesia during the puerperium

0.00

-0.00

0.0

1.1

—

13.65

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.1

—

10.94

—

Hypertensive encephalopathy

0.00

-0.00

0.0

1.5

—

30.06

—

Aortic stenosis

0.00

-0.00

0.0

2.0

—

11.63

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.0

—

23.46

—

Use of pergolide

0.00

-0.00

0.0

1.0

—

10.68

—

Other endophthalmitis

0.00

-0.00

0.0

1.1

—

21.57

—

Use of biperiden

0.95

-0.00

1.0

1.3

22.25

25.86

umol/l

—

Relapsing fevers

0.00

-0.00

0.0

2.2

—

12.60

—

Congenital malformations of nose

0.00

-0.00

0.0

2.8

—

12.28

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

1.4

—

33.37

—

Hypotony of eye

0.00

-0.00

0.0

1.0

—

10.34

—

Congenital deformities of feet

0.98

-0.00

1.3

1.6

38.73

21.09

umol/l

—

Congenital malformations of lung

0.00

-0.00

0.0

3.0

—

22.64

—

Choroidal haemorrhage and rupture

0.00

-0.00

0.0

1.6

—

21.56

—

Aortic stenosis

0.00

-0.00

0.0

1.9

—

11.43

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

2.2

—

11.00

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.9

—

11.07

—

Other cranial nerve disorders in other disorders

0.00

-0.00

0.0

1.2

—

13.52

—

Food allergy

0.00

-0.00

0.0

1.8

—

22.18

—

Dislocation, sprain and strain of joints and ligaments of head

0.97

-0.00

1.9

1.5

14.54

25.76

umol/l

—

Macrocephaly

0.00

-0.00

0.0

2.3

—

11.33

—

Reduction defects of unspecified limb

0.00

-0.00

0.0

1.0

—

11.18

—

Microtia (small ears)

0.00

-0.00

0.0

1.0

—

11.17

—

Malignant neoplasm of thymus

0.00

-0.00

0.0

1.2

—

12.32

—

Deficiency of other/unspecified vitamins

0.00

-0.00

0.0

1.0

—

11.06

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.0

—

13.38

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

1.2

—

13.30

—

Syndactyly

0.00

-0.00

0.0

1.0

—

24.76

—

Disorders of purine and pyrimidine metabolism

0.00

-0.00

0.0

1.3

—

27.90

—

Hypospadias

0.00

-0.00

0.0

4.4

—

13.04

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.4

—

12.06

—

Abnormality of red blood cells

0.00

-0.00

0.0

1.3

—

27.63

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.2

—

12.67

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

23.93

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

-0.00

0.0

1.3

—

27.90

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.6

—

20.74

—

Drug-induced dystonia

0.00

-0.00

0.0

1.2

—

12.10

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.8

—

25.68

—

Vascular dementia

0.96

-0.00

1.8

1.3

18.46

22.81

umol/l

—

Glycosuria

0.00

-0.00

0.0

1.2

—

11.90

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

0.00

-0.00

0.0

1.2

—

13.10

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

1.0

—

13.04

—

Benign neoplasm: Skin, unspecified

1.00

-0.00

1.0

1.3

19.77

26.98

umol/l

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.6

—

24.70

—

Toxic colitis

0.00

-0.00

0.0

1.3

—

19.83

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

1.3

—

12.79

—

Monocytic leukaemia

0.00

-0.00

0.0

1.1

—

13.28

—

Hereditary spherocytosis

0.00

-0.00

0.0

1.5

—

11.62

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.0

—

11.26

—

Benign neoplasm: Thymus

0.00

-0.00

0.0

1.1

—

12.11

—

Postinfectious hypothyroidism

0.00

-0.00

0.0

1.4

—

19.91

—

Drug-induced gout

0.00

-0.00

0.0

1.5

—

22.72

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.0

—

11.68

—

Hereditary sideroblastic anaemia

0.00

-0.00

0.0

1.0

—

22.71

—

Wilms' tumor, including Hilmo

0.00

-0.00

0.0

2.0

—

12.27

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.0

—

26.20

—

Cytomegaloviral pneumonitis

0.00

-0.00

0.0

1.0

—

11.78

—

Malignant neoplasm of accessory sinuses

0.00

-0.00

0.0

1.2

—

13.98

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

12.60

—

Relapsing polychondritis

0.00

-0.00

0.0

1.0

—

22.23

—

Airway disease due to specific organic dust

0.00

-0.00

0.0

1.1

—

12.07

—

Injury of heart

0.00

-0.00

0.0

1.0

—

11.88

—

Obstetric embolism

0.00

-0.00

0.0

1.0

—

29.88

—

Malignant neoplasm of nasal cavity and sinuses

0.00

-0.00

0.0

1.1

—

13.90

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

-0.00

0.0

1.1

—

12.79

—

Acute disseminated encephalitis/encephalomyelitis

0.00

-0.00

0.0

1.0

—

23.75

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

26.94

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.0

—

12.22

—

Meretoja disease

0.00

-0.00

0.0

1.0

—

12.60

—

Malignant neoplasm of nasal cavity and middle ear

0.00

-0.00

0.0

1.2

—

13.90

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.6

—

22.71

—

Malignant neoplasm of meninges, including Hilmo

0.00

-0.00

0.0

1.0

—

13.71

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.4

—

21.43

—

Drug-induced myopathy

0.00

-0.00

0.0

1.6

—

22.06

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.1

—

11.24

—

Alcohol withdrawal state with delirium

0.94

-0.00

1.6

1.4

10.60

26.98

umol/l

—

Chondrosarcoma, including Hilmo

0.00

-0.00

0.0

1.2

—

12.65

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

-0.00

0.0

1.3

—

13.10

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.2

—

12.38

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.0

—

22.76

—

Contact with sharp glass

1.01

-0.00

1.3

1.4

29.21

29.10

umol/l

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.0

—

12.12

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.2

—

26.10

—

Ependymoma

0.00

-0.00

0.0

1.0

—

13.28

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.1

—

22.17

—

Cardiomyopathy, other and unspecified

110

1.00

-0.00

1.5

1.3

23.92

28.21

umol/l

0.19

103

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.0

—

14.00

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.0

—

29.48

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

1.5

—

19.72

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.00

-0.00

0.0

1.2

—

13.82

—

Sickle-cell disorders

0.00

-0.00

0.0

1.0

—

23.84

—

Unspecified transport accident

0.00

-0.00

0.0

1.1

—

21.92

—

Diphtheria

0.00

-0.00

0.0

2.0

—

22.91

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.4

—

22.05

—

Benign neoplasm: Ciliary body

0.00

-0.00

0.0

1.2

—

12.68

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

13.57

—

Drowning and submersion while in natural water

0.00

-0.00

0.0

2.2

—

11.52

—

0.00

-0.00

0.0

1.3

—

22.99

—

Other cestode infections

0.00

-0.00

0.0

1.0

—

12.25

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.3

—

12.49

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.3

—

13.58

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.1

—

21.25

—

Hip and thigh

0.00

-0.00

0.0

1.3

—

25.43

—

Diphtheria

0.00

-0.00

0.0

2.0

—

22.91

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

14.22

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

-0.00

0.0

1.1

—

23.14

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.3

—

13.50

—

Chronic thyroiditis

0.00

-0.00

0.0

1.0

—

11.33

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.0

—

25.29

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

0.00

-0.00

0.0

1.2

—

27.92

—

0.00

-0.00

0.0

1.2

—

12.56

—

Need for immunization against other single infectious diseases

0.00

-0.00

0.0

4.2

—

11.60

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.3

—

25.50

—

Other infestations

0.00

-0.00

0.0

1.2

—

13.20

—

Left side

0.00

-0.00

0.0

1.6

—

20.96

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

-0.00

0.0

2.4

—

13.72

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.0

—

13.30

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Zinc [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS